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Background: People with type 2 diabetes (T2D) may go undiagnosed and subsequently be 
hospitalized with T2D.  
 
Objective: Determine the percentage of Canadians, with unreported T2D, who experience a 
T2D hospitalization  
 
Methods: Using linked dataset, respondents who reported no diabetes in the Canadian 
Community Health Survey, were followed in the Discharge Abstract Database for T2D 
hospitalization event.  
 
Results: 0.56% of men and 0.44% of women, who reported no diabetes, were hospitalized 
with T2D. Older Age, higher BMI and worse self-reported health increased T2D 
hospitalization in both men and women. In women, drinking alcohol, smoking tobacco and 
lower physical activity were associated with an increase in T2D hospitalization. 
 
Conclusion: Significant proportion of Canadians experience a T2D hospitalization when self-
reporting undiagnosed diabetes. Potential risk factors were identified; however, further 
research needs to focus on understanding these relationships. 
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Summary for Lay Audience 
Type 2 diabetes (T2D) is a growing public health concern and early detection and 
management is key to controlling the pandemic. Since T2D can be present for a long time 
before patients start experiencing symptoms, some Canadians may be unaware of having the 
condition. These individuals may eventually present to the hospital with related 
complications.  
 
The objective of this thesis was to determine what percentage of Canadians who reported not 
having T2D, might actually have the disease and end up in the hospital with related 
condition. This thesis assessed whether the percentage of Canadians who reported no 
diabetes but were hospitalized with T2D related condition changed over time. Lastly, this 
thesis looked at potential factors that might increase or decrease T2D hospitalization risk 
among this group.  
 
This thesis utilized a national self-reported survey (Canadian Community Health Survey 
[CCHS]) and national hospitalization records (Discharge Abstract Database [DAD]). 
Canadians who responded to the CCHS and reported no previous T2D diagnosis were 
followed in the DAD to see if they experienced a related hospitalization.  
 
This thesis found that 0.56% of men and 0.44% of women were hospitalized with T2D even 
though they reported no diabetes. This percentage increased with each year for men between 
2000 to 2009 from 0.41% to 0.71%. With increasing age, higher BMI and self-reported poor 
health, Canadians were more likely to be hospitalized with T2D. In Canadian women, 
alcohol drinking prevented T2D hospitalization, while smoking tobacco, and lower physical 
activity were associated with increase in T2D hospitalization. 
 
Identifying T2D early could be an effective strategy to minimize the long‐term impacts of the 
disease. Future research should focus on linking other administrative datasets, such as 
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Chapter 1  
1 Diabetes in Canada 
This chapter will provide background information to contextualize the study rationale by 
introducing diabetes, discussing the health and economic consequences of diabetes and 
defining undiagnosed diabetes and its health consequences. Lastly, this chapter will 
identify the study objectives.  
1.1 Types of diabetes 
Diabetes is a chronic disease that occurs either when the pancreas does not produce 
enough insulin or when the body does not respond appropriately to insulin (a hormone 
that is released by the pancreas to regulate blood sugar).[1] Although many types of 
diabetes have been described, there are three main types: type 1, type 2 and gestational 
diabetes.[2] Type 1 diabetes, an autoimmune disease, is characterized by decreased 
insulin production. It requires daily administration of insulin for management.[2] Type 2 
diabetes (T2D), results from the ineffective use or production of insulin.[2] Gestational 
diabetes is characterized by hyperglycemia during pregnancy and typically disappears 
following childbirth.[2] Other types of diabetes are uncommon and include those 
associated with genetic defects, surgeries, and specific medications that affect the body’s 
ability to produce or respond to insulin.[2]  
1.2 Diabetes prevalence and incidence 
The prevalence of diabetes is growing in Canada and in other parts of the world, 
especially T2D. In 2014, there were 422 million adults worldwide living with diagnosed 
diabetes, compared to 108 million in 1980 (rising from 4.7% to 8.5%).[3] In Canada, 
8.1% of the population was living with diagnosed diabetes between 2013 and 2014; an 
increase of 37% from 2003 to 2004.[4] By 2025, the prevalence of diagnosed diabetes is 
estimated to reach 12.1% (5 million people).[5] More than 90% of people with diagnosed 
diabetes have T2D,[4] which is the focus of this thesis.  
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Although a consistent rise in prevalence of T2D has been observed, the incidence of T2D 
increased until 2006–2007, from 6.7 to 7.6 per 1,000 population, but then decreased to 
6.3 per 1,000 population by 2013–2014.[4] This may be because Canadians with T2D 
now live longer due to advancements in treatment of patients diagnosed with T2D.[6] 
The number of Canadians living with T2D is also expected to increase in the coming 
years due to the aging population.[4]  
1.3 Health consequences of type 2 diabetes 
With long-term T2D, there are risks of complications, typically categorized as 
macrovascular (due to damage to larger blood vessels) and microvascular complications 
(due to damage to small blood vessels).[7] Macrovascular complications include 
cardiovascular diseases (CVD) such as heart attacks, strokes and insufficiency in blood 
flow to legs.[7] Microvascular complications include retinopathy, nephropathy and 
neuropathy.[7]  
Cardiovascular disease is an umbrella term for all types of diseases that affect the heart or 
blood vessels.[7] This includes coronary heart disease, which can cause heart attacks, 
stroke, and peripheral artery disease.[7] People with T2D are two to four times more 
likely to have CVD compared to people without T2D; CVD accounts for a large 
proportion of the excess mortality related to T2D.[8–10] T2D has been associated with 
earlier development of CVD; men and women with T2D tend to be about 15 years 
younger than those without T2D in the same CVD risk category.[10] 
Diabetic retinopathy, typically occurs in individuals who have had T2D for several 
years.[7] It is caused by small blood vessel damage to the back layer of the eye.[7] 
Diabetic retinopathy is a leading cause of blindness and visual disability.[7] Up to 21% of 
patients with T2D have retinopathy at the time of diagnosis, and most develop some 
degree of retinopathy over time.[11] The prevalence of diabetic retinopathy has been 
shown to vary from 28.8% in persons who had T2D for less than five years to 77.8% in 
persons who had T2D for 15 or more years.[12] 
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Nephropathy is also caused by damage to small blood vessels in the kidneys.[7] This can 
cause kidney failure, and lead to death.[7] In developed countries, diabetic nephropathy is 
a leading cause of dialysis and kidney transplant.[7] Approximately, 30 to 50% of 
individuals with T2D have nephropathy; the prevalence of nephropathy ranges between 
25% in younger T2D patients (<65 years old) to nearly 50% in older T2D patients (65 
years old).[13] 
Lastly, neuropathy, the most common complication of T2D, is nerve damage caused by 
hyperglycemia and decreased blood flow to small blood vessels.[7] This nerve damage 
can lead to sensory loss, gastrointestinal side effects, impotence in diabetic men.[7] 
Overall, two thirds of T2D patients have objective evidence for some variety of 
neuropathy, but only about 20% have symptoms.[14] The prevalence of neuropathy has 
been shown to be 22% in youth with T2D.[15] 
1.4 Economic consequences of type 2 diabetes 
T2D has a number of economic consequences including medical costs, lost productivity, 
premature mortality, and intangible costs in the form of reduced quality of life.[16] The 
global economic burden of T2D was estimated to be $1.3 trillion USD in 2015 which 
accounts for 1.8% of the world’s GDP.[16] Indirect costs, such as reduced productivity, 
work absences and inability to work due to T2D related disability, accounted for 35% of 
the total burden. Relative to GDP, T2D has a significant impact on North America as 
well as in middle-income countries.[16] The absolute costs are expected to increase to 
$2.1 trillion USD by 2030. This translates to an increase in costs as a share of global 
GDP from 1.8% in 2015 to a 2.2% in 2030.[17]  
The economic burden of T2D in Canada is estimated to increase from $6.3 billion 
annually in 2000 to $16.9 billion by 2020.[18] T2D associated costs accounted for $3.5% 
of public health care spending in Canada with direct costs representing about 17% of the 
total cost.[18] Diabetes Canada has projected the overall direct cost of T2D to be $3.1 
billion in 2020.[18] 
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These health care costs of T2D arise due to the need for acute inpatient hospitalizations, 
physician visits, prescription medications and assistive devices.[19] Inpatient 
hospitalization accounted for nearly 50% of attributable costs in incident T2D cases.[19] 
Between 2011/2012 and 2021/2022, 2.16 million new cases of T2D are estimated to 
result in $15.36 billion in Canadian health care costs, almost two-thirds of which will be 
spent on acute hospitalizations and physician services.[20] 
1.5 Undiagnosed type 2 diabetes 
The onset of T2D is characterized by a gradual increase in fasting and post-prandial (i.e. 
after meals) blood sugar. It can take 9-12 years before glycemic levels are sufficiently 
high to lead to symptoms and a diagnosis of T2D.[21] Consequently, individuals who 
have T2D can spend a significant period of time unaware that they have the disease.[2] 
This is referred to as undiagnosed T2D; and is typically defined as those whose T2D has 
not been diagnosed by a physician but whose plasma glucose levels satisfy established 
criteria for T2D.[22] During this period, patients may not receive the treatment that they 
need for diabetes, which may result in development of complications before diabetes 
diagnosis.[2] These complications can include  heart disease, stroke, kidney failure, nerve 
damage, blindness, erectile dysfunction and amputation; complications which can  
impose enormous strains on the health care system.[23]  
As such, the Diabetes Canada 2018 clinical practice guidelines recommend that all 
individuals be evaluated annually for T2D risk based on their demographic and clinical 
profile. The guidelines recommend that people aged 40 years and over be screened every 
three years for T2D or more frequently (every 6 to 12 months) for those at very high 
risk.[24] The hope is to capture T2D early in its progression and prevent the development 
of T2D related complications. Despite these practice guidelines, the Public Health 
Agency of Canada reported that the prevalence of total T2D may be underestimated by 
30% as a result of undiagnosed T2D.[25]  
1.5.1 Health consequences of undiagnosed type 2 diabetes  
The health outcomes are worse for individuals living with undiagnosed T2D compared 
with individuals who have been previously diagnosed.[26–28] In hospitalized patients, 
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undiagnosed T2D patients, compared to known T2D patients, had an increased risk of 
morbidity, mortality, extended hospital length of stay and more adverse outcomes 
following discharge.[26] Patients with previously undiagnosed T2D were 28% more 
likely to experience death within 30 days from myocardial infarction compared to 
patients without T2D.[27] Among those who have undergone coronary bypass 
operations, 5.2% had undiagnosed T2D and faced a higher mortality rate than those with 
diagnosed T2D.[28]  
Similar data exist in Canada, where those with T2D diagnosed at a later stage were more 
likely to be hospitalized and had a longer length of hospital stay compared with those 
with an early diagnoses.[29] Cardiovascular disease had a greater impact on females with 
T2D than males, especially when diagnosed at a later stage.[29] Females who were 
diagnosed with T2D late had three to four times increased risk of CVD mortality and 
CVD hospitalizations compared with their male counterparts who were diagnosed 
late.[29]  
All-cause mortality risk has shown to be similar in subjects with diagnosed and 
undiagnosed T2D, despite undiagnosed T2D patients having a lower cardiovascular risk 
profile than those with diagnosed T2D.[30] A Canadian study reported that despite the 
patient charts indicating dysglycemia among patients admitted to the hospital for 
coronary heart disease, glucose monitoring occurred less than 30% of the time.[31]  
1.6 Preventable hospitalizations and type 2 diabetes 
T2D is a chronic condition that can be managed in a primary care setting. As such it is 
considered to be an ambulatory care-sensitive condition (ACSC) as hospitalization for 
this condition might be preventable.[32–34] There is evidence to suggest that a regular 
source of primary care and maintaining glucose levels can result in fewer T2D 
hospitalizations.[35,36] When individuals have access to primary care, are cared for 
effectively, have screening in a timely manner and are supported in managing a chronic 
condition like T2D, patients face a lower risk of acute complications and 
hospitalizations[36,37]. Those with undiagnosed diabetes might face more complications 
requiring presentation to hospital.[37]  
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Between 2001 to 2005, an estimated 4.2 million Canadians aged 12 to 74 experienced at 
least one preventable hospitalization; T2D related hospitalizations represented 30% of 
these hospitalizations.[38] Studies conducted in single emergency departments in the 
United States estimated that approximately 9% of patients who presented to the 
emergency department for acute illness had previously undiagnosed T2D.[39–41] In 
Europe, 9.5% of those presenting to hospital had previously undiagnosed T2D.[42] Those 
with undiagnosed T2D were admitted to hospital predominantly for cardiac disorders, 
nervous system disorders such as cerebral infarction, and infections/infestations.[42] In 
Canada, there is little understanding of  the proportion of patients with undiagnosed T2D 
who present to hospital, along with a lack of data on trends in T2D related preventable 
hospitalizations among undiagnosed T2D patients.  
Overall, a decrease in T2D related preventable hospitalizations has been documented in 
Canadian studies, which may suggest a sustained improvement in T2D care, despite the 
increase in the T2D prevalence.[43,44] In Alberta and British Columbia, declining T2D 
related preventable hospitalization was observed between 1998 and 2009.[43] Whereas in 
Ontario, between 1994 and 1999, hospital admissions for hyperglycemic emergencies 
decreased by 33%.[44] However, these studies investigated the temporal trends among 
individuals with previously diagnosed diabetes.  
1.7 Rationale and objectives 
Diagnosing T2D at an early stage is key to preventing complications, avoiding 
hospitalizations, and reducing health care costs.[45] It has been shown that the intensity 
of glucose, blood pressure and cholesterol treatment after diagnosis is less important than 
the time of treatment initiation.[45] Therefore, early detection of T2D is of utmost 
importance as screening strategies can decrease the incidence of myocardial infarction, 
decrease T2D related microvascular complications, and increase the number of Quality 
Adjusted Life Years (QALY).[46]  
Currently, no Canadian literature exists on the proportion of individuals with 
undiagnosed diabetes who present to the hospital with T2D. Furthermore, no Canadian 
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literature has examined national trends in T2D related hospitalizations among patients 
with undiagnosed T2D.  
Lastly, it is important to study the factors associated with undiagnosed T2D requiring 
hospitalization and whether these determinants differ for males and females. There is 
literature that explores sociodemographic, health-related and behavioural factors 
associated with T2D hospitalization. However, these studies have not examined these 
factors in the context of undiagnosed T2D patients. Therefore, the objectives of this 
thesis are as follows:  
Objective 1: Identify the percentage of men and women in Canada with undiagnosed 
T2D who experience T2D related hospitalizations.  
Objective 2: Explore temporal trends of T2D related hospitalizations among Canadian 
men and women with undiagnosed T2D. 
Objective 3: Explore the role of sociodemographic, health-related, and behavioural 
factors associated with T2D related hospitalizations among Canadian men and women 
with undiagnosed T2D.  
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Chapter 2  
2 Literature Review 
This chapter will lay out the etiology of T2D and its potential risk factors. This chapter 
will explain how T2D is diagnosed, which will lay a foundation to further discuss the 
prevalence, temporal trends and risk factors for undiagnosed T2D. Furthermore, this 
chapter will review the prevalence of T2D hospitalizations as well temporal trends and 
risk factors of T2D hospitalization. Literature looking at undiagnosed diabetes in hospital 
setting will be summarized. Lastly, this chapter will summarize the in-depth literature 
review, restate the objectives of this study and present hypotheses.  
2.1 Glucose regulation in type 2 diabetes 
In order to ensure normal body function, the human body maintains a tight control of its 
blood glucose levels.[47] This is accomplished by a highly complex network of various 
hormones and neuropeptides released mainly from the brain, pancreas, liver, intestine as 
well as adipose and muscle tissue.[47] The pancreas plays a key role by secreting the 
blood sugar-lowering hormone insulin and glucagon.[47] When blood glucose levels are 
low, the pancreas secretes glucagon, which increases blood glucose levels through 
glycogenolysis (conversion of glycogen into glucose).[47] When blood glucose levels are 
high, insulin is released to trigger glucose uptake into insulin-dependent muscle and 
adipose tissues as well as to promote glycogenesis (conversion of glucose into 
glycogen).[47]  
Disturbances in the interplay of the hormones and peptides involved may lead to 
metabolic disorders such as T2D.[48] T2D usually begins with insulin resistance, a 
condition in which muscle, liver, and fat cells do not use insulin well.[48] As a result, the 
body needs more insulin to help glucose enter cells. At first, the pancreas produces more 
insulin to keep up with the added demand.[48] This is referred to as the prediabetes stage. 
In the prediabetes stage the blood sugar levels might not be high enough to be considered 
T2D, however, long-term complications such as microvascular and macrovascular 
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disorders may manifest in some people.[49] Over time, the pancreas cannot produce 
enough insulin and blood glucose continue to rise[48]  
Although T2D may remain asymptomatic for many years, some of the symptoms as a 
result of hyperglycemia include increased thirst, increased hunger, dry mouth, frequent 
urination, unexplained weight loss, fatigue, blurred vision, headaches and rarely loss of 
consciousness.[3] 
2.2 Type 2 diabetes risk factors 
Numerous risk factors have been investigated and linked to T2D. Overweight and obesity 
are the most significant risk factors. Adults with a body mass index (BMI) of 40 or higher 
are 7.37 times more likely to be diagnosed with T2D.[50] For people with obesity, T2D is 
associated with poor control of blood sugar, blood pressure and cholesterol levels and 
many of the health complications of T2D become more severe when they are 
compounded by overweight or obesity.[50–52]  
Other factors such as age, sex, marital status, education, socioeconomic status (SES) and 
ethnicity have also been linked to T2D. For instance, the prevalence and incidence of 
diagnosed T2D has been shown to increase with age and is higher among males (8.7% 
and 6.5 per 1,000 population) than among females (7.6% and 5.3 per 1,000 
population).[4] A systematic review and meta-analysis of six observational studies 
conducted in different parts of the world found that marital status also increased the risk 
of T2D by 26% when there was a spousal history of T2D.[53] Furthermore, a recent 
systematic review and meta-analysis of 23 observational studies from different parts of 
the world concluded that compared with a higher educational level and income, lower 
educational levels and income were associated with an increased risk of T2D.[54] Social 
determinants of health not only increase the risk of developing T2D but can also have an 
impact on health outcomes, such as glycemic control, low density lipoproteins and blood 
pressure for a person with T2D.[55,56] Additionally, ethnicity has been linked with T2D. 
For example, a study in the United States found that compared with white participants, 
Black and Asian participants were twice as likely to have T2D.[57] The incidence of T2D 
has been shown to be highest among South Asians, particularly 20 to 29-year-olds, with 
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rates 2.2 times that of white individuals and 3.1 times that of Chinese individuals.[58] 
Lastly, multiple studies have shown higher rates of T2D among Indigenous people in 
Canada compared to non-Indigenous Canadians while controlling for other 
sociodemographic characteristics.[2,59,60] 
Although it does not have a clear pattern of inheritance[61] at least 38 T2D associated 
genes have been identified, however, only about 10% of the heritability of T2D can be 
explained by these genes.[61–63] Many affected individuals have at least one close 
family member, such as a parent or sibling, with the disease.[64] The increased risk is 
likely due to shared genetic factors and lifestyle influences that are shared by members of 
a family.[63]  
Modifiable health behaviours such as unhealthy diet, smoking tobacco, alcohol drinking 
and physical inactivity have also been associated with T2D. A systematic review and 
meta-analysis of 25 cohort studies found that active smoking is positively associated with 
an increased risk of T2D.[65] The association between the number of cigarettes smoked 
and T2D risk was consistent with a dose-response phenomenon.[65] Moderate alcohol 
drinking, relative to abstainers (current non-drinkers and never drinkers), played a 
protective role against T2D according to a systematic review of 38 observational 
studies.[66] However, reductions in risk appeared to be specific to women, who exhibit a 
decreased risk of T2D with moderate alcohol consumption.[66] Other health behaviours 
such as increasing the amount of green leafy vegetables in an individual’s diet has been 
shown to help reduce the risk of T2D.[67,68] Habitual consumption of sugar sweetened 
beverages has been shown to be associated with a greater incidence of T2D, 
independently of adiposity.[69] Furthermore, meat consumption has shown to increase 
risk of T2D.[70] Lastly, there is strong evidence for an inverse association between 
physical activity and risk of T2D, which may partly be mediated by reduced 
adiposity.[71] 
2.3 Onset of type 2 diabetes 
A highly cited study by Harris et al. estimated the onset of T2D to be 9 to 12 years before 
its clinical diagnosis.[21] This was based upon the prevalence of retinopathy at time of 
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diagnosis of T2D. The authors estimated that 20.8% of patients with diagnosed T2D in 
United States and 9.9% of patients in Australia had retinopathy at time of T2D 
diagnosis.[21] Under the assumption that retinopathy increased linearly with longer 
duration of T2D, they extrapolated that the onset of detectable retinopathy occurred 4 to 7 
years before diabetes diagnosis.[21] Because research has indicated that T2D may be 
present for 5 years before retinopathy becomes evident, authors concluded that in some 
cases, the onset of T2D may occur 9 to 12 years before its clinical diagnosis.[21]  
A more recent study aimed to extrapolate the mean duration of undiagnosed T2D from 
the proportion of subjects with observable retinopathy at diagnosis of T2D.[72] They 
performed eyes examination and ascertained date of first diagnosis of T2D.[72] Of the 
295 patients examined, 14.68% had some form of retinopathy at time of diagnosis. The 
findings suggested that detectable retinopathy occurred 5.8 years before actual 
diagnosis.[72] The fact that a period of dysglycaemia is likely to predate development of 
retinal changes, this study implied that the duration of undiagnosed T2D is longer, about 
10 years.[72] 
Even still, there was debate as to whether the relation between retinopathy and duration 
of T2D is a linear one.[73] Porta et al. further argued the plausibility of such a long 
duration of undiagnosed T2D in countries with regulated health care systems in which 
blood glucose concentrations are ideally measured more often than every 10 years due to 
T2D guidelines.[73] Using Akaike Information Criterion and coefficient of determination 
to choose the best-fitting model, the authors concluded that T2D may be present 4 to 6 
years before clinical diagnosis.[73]   
2.4 Diagnosis of type 2 diabetes 
The following tests can be used in clinical setting to diagnose T2D: fasting blood glucose 
(FPG) test, glycated hemoglobin (A1C) test, oral glucose tolerance (OGT) test and 
random glucose test (RGT).[74] An FPG test is typically taken after an overnight fast and 
[74] T2D is diagnosed with a FPG level of 126 mg/dL (7 mmol/L) or higher on two 
separate tests.[74] A1C  is a blood test which measures blood sugar attached to 
hemoglobin, and represents blood sugars over 2-3 months.[74] The higher the blood 
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sugar levels, the more hemoglobin have sugar attached.[74] An A1C level of 6.5 percent 
or higher on two separate tests indicates a T2D diagnosis.[74] An OGT test requires 
individuals to fast overnight.[74] A sugary liquid is consumed the day of the test and 
blood sugar levels are tested periodically for the next two hours.[74] A reading of more 
than 200 mg/dL (11.1 mmol/L) after two hours indicates T2D.[74] Lastly, a RGT can be 
administered anytime to measure blood glucose levels and a reading of more than 200 
mg/dL (11.1 mmol/L) may suggest diabetes.[74]  
The diagnostic criteria for T2D are based on thresholds of glycemia that are associated 
with microvascular disease, especially retinopathy.[74] To confirm T2D cases, a plasma 
glucose in the T2D range should be confirmed with a secondary test in asymptomatic 
individuals.[74] This is because hyperglycemia detected under acute event or other stress 
may be transitory.[75] This does not in itself confirm a diagnosis of T2D.[75] If two tests 
are above the T2D threshold, then a diagnosis of T2D is confirmed.[74,75] Table 2.1 
from Diabetes Canada guidelines summarizes T2D diagnostic tests criteria.[74] 
Table 2.1: Type 2 diabetes diagnosis criteria 
Test Normal Range 
FPG  7.0 mmol/L 
A1C  6.5% 
OGT  11.1 mmol/L 
RGT  11.1 mmol/L 
 
2.5 Undiagnosed type 2 diabetes 
Globally, nearly half of all T2D cases are considered undiagnosed.[76] However, the 
prevalence of undiagnosed T2D shows geographic variation. Undiagnosed T2D  has been 
reported to be as low as 10% of total T2D (0.9% of population) in higher income 
countries such as Ireland,[77] and as high as 55% of total T2D (3.96% of population) in 
low income countries such as rural Bangladesh.[78]  
A Canadian study assessed the prevalence of undiagnosed T2D in patients over the age of 
40 who visited their family physicians for routine care.[79] Patients were asked to fill out 
a questionnaire indicating whether they had been previously diagnosed with T2D. Those 
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who indicated no previous diagnosis were tested for T2D.[79] They found previously 
undiagnosed T2D in 2.2% of patients after screening in the primary care setting.[79] A 
higher percentage of men (2.4%) than women (2.0%) had previously undiagnosed 
T2D.[79] However, the authors noted that these prevalence estimates maybe biased since 
the study population may not have been entirely representative of the Canadian 
population over 40 years of age.[79] For instance, the study sample had a T2D prevalence 
of 16.4%, which is much higher than the rate of T2D in the general Canadian 
population.[79] 
A more recent Canadian study conducted in 2005 using Canadian Health Measure Survey 
(CHMS) data aimed to estimate the prevalence of undiagnosed T2D in Canada.[80] 
CHMS collected self-reported health data through household interviews.[80] 
Additionally, the CHMS collected direct physical measures such as biospecimens using 
mobile examination centers.[80] This study found that 1.13% (~20% of total T2D) of the 
Canadian adult population had undiagnosed T2D based on FPG levels; whereas 3.09% 
(~40% of total T2D) of the Canadian adult population was classified as undiagnosed T2D 
using A1C level as a criterion.[80] Undiagnosed T2D was defined as not self-reporting 
T2D and having a blood glucose level that met the diagnostic criteria.[80] The proportion 
of undiagnosed T2D prevalence was higher for males compared with females (22% vs. 
18% of total T2D, respectively) under the FPG criterion, whereas under the A1C 
criterion, the proportion of undiagnosed T2D prevalence was lower for males compared 
with females (37% vs. 46% of total T2D, respectively).[80] Studies have shown that the 
A1C test has a low sensitivity and high specificity for identifying T2D, which varied as a 
function of age and race.[81,82] This is to say that while the A1C test at the 6.5% 
diagnostic threshold may be good at ruling out T2D, it may wrongly classify non-diabetic 
individuals as having T2D. Furthermore, the study used data which excluded Canadians 
living on reserves or on Crown lands, people residing within institutions, those from 
certain remote geographical regions, and full-time members of the Canadian Forces.[80] 
Therefore, these estimates might also be biased in estimating the true prevalence of 
undiagnosed T2D.[80]  
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2.5.1 Temporal trends in undiagnosed type 2 diabetes 
There is evidence to suggest that undiagnosed T2D as a proportion of total T2D has 
significantly declined since the 1970s to early 2000s due to rigorous screening for those 
at higher risk.[83] Undiagnosed T2D as proportion of total T2D declined from 40% in 
1988 to 31% in 2012 in the United States (US) according to one study.[57] This was true 
across age, sex, race, educational level and income groups except for younger 
participants (age 20-44, 40.4% in 1988 to 40.4% in 2012).[57] Similarly, in the US, the 
incidence of T2D increased sharply during 1990 and 2008, before leveling off with no 
significant change during 2008 and 2012.[84] The incidence per 1,000 persons was 3.2 in 
1990, 8.8 in 2008, and 7.1 in 2012.[84]  
Certainly there has been a sharp decline in undiagnosed T2D as a proportion of total 
T2D; however, in the US, temporal trends in the crude prevalence of undiagnosed T2D 
remained stable over time.[85–87] Rates of undiagnosed T2D fluctuated between 3.1% to 
3.9% of total population during the period of 1988 and 2012. Even though more T2D 
cases were detected, the crude prevalence of undiagnosed T2D did not change. This may 
be due to an increase in new cases of T2D. Obesity is on the rise, putting people at higher 
risk for developing T2D, especially in young adults.[88,89] The leveling off of T2D 
incidence rates in 2012 might not necessarily suggest a decrease in T2D cases. Younger 
adults who may have T2D might go unnoticed and hence would explain the unchanged 
crude prevalence of undiagnosed T2D despite higher detection rates.  
The temporal trends studies mentioned above used survey data that used single FPG, 
OGT or AlC tests measurements to determine undiagnosed T2D in the US. Such single 
measurements may not provide a confirmatory T2D diagnosis. A more recent study in the 
US re-examined the crude prevalence of confirmed undiagnosed T2D. Confirmed 
undiagnosed T2D was defined as both elevated levels of fasting glucose and A1C (fasting 
glucose ≥7.0 mmol/L and A1C ≥6.5%) in persons without diagnosed T2D.[90] They 
estimated undiagnosed T2D crude prevalence increased during the past two decades 
(from 0.89% in 1988 to 1994 to 1.2% in 2011 to 2014) but has decreased over time as a 
proportion of total T2D cases.[90] This is much lower than the prevalence provided in the 
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studies above. Additionally, this study also suggested an increase in crude prevalence of 
undiagnosed T2D whereas the previous studies noted a stabilization of undiagnosed T2D. 
Other high-income countries with similar health care systems, such as Germany, have 
also seen a decline in the prevalence of undiagnosed T2D as proportion of total T2D 
(3.8% to 2.0% between 1997-2011).[91] However, the crude undiagnosed T2D 
prevalence has remained stable.[91] Although there is literature on the estimated 
prevalence of undiagnosed T2D in Canada,[80] thus far, no literature exists on trends 
over time in the prevalence of undiagnosed T2D. With increasing rates of obesity 
observed in Canada,[92,93] incidence of new T2D might also increase leading to no 
change observed in the crude prevalence of T2D despite the increase in detection rate. 
2.5.2 Undiagnosed type 2 diabetes risk factors 
Both ethnicity and obesity have been linked not only with diagnosed T2D, but also with 
undiagnosed T2D. Members of some minority groups not only have elevated risk of 
developing T2D but are also more likely to go undiagnosed; especially in Asian, 
Hispanics and black participants in some studies.[94–97] For example, undiagnosed T2D 
crude prevalence was two times higher in non-Hispanic blacks and Mexican Americans 
than in non-Hispanic whites.[86] Obesity, a risk factor for undiagnosed T2D, is also 
higher among racial minority groups.[98,99] Another study results found undiagnosed 
T2D was more common in overweight or obese adults, older adults and racial/ethnic 
minorities (including Asian Americans).[90] 
Some sociodemographic characteristics such as income, education, sex and rurality are 
also risk factors for undiagnosed T2D. Individuals with less than a high school education 
were twice as likely to have undiagnosed T2D compared to individuals with higher 
education level.[100] Individuals in lower income quintiles were also twice as likely to 
have undiagnosed T2D compared to individuals in middle income groups.[100] At the 
national level, undiagnosed T2D prevalence was higher among men (5.0%) than among 
women (3.2%).[101] Furthermore, a Canadian study found higher rates of undiagnosed 
T2D in rural patients compared to urban patients (2.0% vs 2.9%, respectively).[79]  
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There is also evidence to suggest that receiving health care in the past year and routine 
patterns of primary health care utilization were associated with undiagnosed 
T2D.[102,103] People with undiagnosed T2D were more likely than those with 
diagnosed T2D to report not having made any health care visits in the past year (39.2% 
versus 13.4%, respectively) and not having a place to go for primary health care (16.6% 
versus 3.7%, respectively).[102] A Canadian study examined risk factors for undiagnosed 
T2D and classified patients diagnosed with T2D as ‘early’ or ‘late’ depending on when 
T2D related comorbidities or complications had developed at the time of 
diagnosis.[104] This study found that patients with a late T2D diagnosis were less likely 
to report having a regular medical doctor.  
Factors such as smoking tobacco, alcohol drinking, physical activity and fruit and 
vegetable consumption have been studied and associated with undiagnosed T2D. Both 
smoking and drinking were shown to be risk factors for undiagnosed diabetes.[105] 
Current smokers compared to those who have never smoked had 1.47 higher odds of 
undiagnosed diabetes.[105] Daily drinking also put individuals at 1.64 higher odds of 
having undiagnosed diabetes.[105] In contrast, a Chinese study found current smoking to 
be a protective factor against undiagnosed diabetes.[106] Another study conducted in 
United Kingdom investigated the association between fruits and vegetable consumption 
in subjects aged 40 to 64 years.[107] Participants underwent an OGT test, and their fruit 
and vegetable consumption was assessed.[107] Frequency of average yearly vegetable 
consumption was inversely associated with the risk of having undiagnosed T2D (Odds 
Ratio [OR]= 0.18) and the effect remained significant after adjusting for age, sex and 
family history; however the effect diminished after adjusting for BMI.[107] Individuals 
who reported frequent average yearly fruit consumption were less likely to have 
undiagnosed T2D than were those who reported infrequent consumption, but this 
relationship was not significant (OR = 0.52). [107] In contrast, another study found that 
increase in vegetable consumption was a protective factors against undiagnosed diabetes 
but only in women (OR = 0.56).[108] Additionally, 70% of undiagnosed T2D individuals 
reported physical inactivity, which was much higher than those with diagnosed T2D 
(56%) and non-T2D individuals (50%).[109] 
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2.6 Preventable hospitalizations 
As defined by the Canadian Institute of Health Information (CIHI), ACSC includes 
epilepsy, chronic obstructive pulmonary disease, asthma, heart failure and pulmonary 
edema, hypertension, angina and diabetes.[110] Hospitalization due to those condition 
are considered potentially preventable; rates of preventable hospitalization has been used 
an indicator of the quality and performance of primary care system.[110] T2D related 
hospitalization are considered potentially preventable, as uncontrolled T2D can result in 
complications that can require extensive care, including hospitalization.[111,112].  
In 2011, preventable hospitalizations comprised approximately 6% of all 
hospitalizations.[38] Among those with a preventable hospitalization, 20% were 
hospitalized for T2D.[38] In European countries with a similar health care system as 
Canada, T2D hospitalization ranged from 4% to 14% of total preventable 
hospitalizations.[113] In the Canadian context, a study from western provinces found that 
the rate of yearly hospitalization among patients diagnosed with T2D was 1.1% in 
Alberta and 0.8% in British Columbia.[43] In Ontario, 31.8% of T2D patients had at least 
one emergency department visit and 13.7% had a hospitalization due to T2D related 
hospitalization.[114]  
2.6.1 Temporal trends in type 2 diabetes related hospitalizations 
Overall, a decrease in T2D related hospitalizations has been documented in studies, 
which may suggest a sustained improvement in T2D care, despite the increase in the T2D 
prevalence.[33,43,115] Overall, preventable hospitalization rates in Canada have 
decreased by 22% between 2001-2002 and 2006-2007, after population growth and aging 
were taken into account.[33] This decline is greater than the 14% drop observed for all 
medical hospitalizations over the same period.[33] In 1998, the adjusted preventable 
hospitalization rate for T2D among diagnosed T2D patients was 2.9% in Alberta and 
1.7% in British Columbia, compared to 1.1% and 0.8% in 2009, respectively.[43] 
Overall, the number of people with T2D more than doubled in both provinces between 
1998 and 2009.[43] The number of hospitalizations also increased but at a much slower 
pace, translating into decreasing rates of hospitalization over the study period.[43] 
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Between 1994 and 1999, hospital admissions for hyperglycemic emergencies in Ontario 
decreased by 33%. There was also a marked decline in hospital admissions for 
hypoglycemia and an associated decrease in emergency department visits for T2D.[44] 
Studies examining trends of T2D related preventable hospitalization among patients 
diagnosed diabetes have shown a declining trend in the US as well.[43,116,117] In the 
US, T2D related preventable hospitalization (including uncontrolled T2D, short and long 
term complications and lower extremity amputations) declined 27% from 1988 to 
2008.[116] This was true for all ages except for those between 18 and 44 who showed no 
significant change in the rates of T2D related hospitalization.[116] During the period of 
2005 to 2014, the annual count of T2D hospitalizations increased from 500,444 to 
577,040. However, no changes were observed in the rate of T2D related hospitalization 
among individuals with T2D.[117] Subgroup analysis revealed a significant increase in 
T2D related hospitalizations due to acute complications in the age-group 18–44 
years.[117] The slight increase in hospitalization rates due to T2D short-term 
complications balanced by a slight decrease in hospitalization rates due to uncontrolled 
T2D led to no observable change in hospitalization rates during 2005 to 2015 in the 
US.[117]  
2.6.2 Preventable hospitalization and undiagnosed diabetes 
Preventable hospitalization definitions pertains to hospitalizations experienced by 
individuals diagnosed with ACSC. However, for the purpose of this thesis, the definition 
was extended to include individuals who reported undiagnosed diabetes. If individuals 
were diagnosed in a timely manner, they might have not developed conditions requiring 
hospitalizations. Therefore, these hospitalization could have been prevented as well.  
2.6.3 Risk factors of type 2 diabetes related hospitalization 
Several sociodemographic risk factors such as sex, education, marital status and income 
have been associated with increased rates of T2D related hospitalization. Hospitalized 
individuals with T2D were shown to have lower educational status, lower household 
income, and were unmarried compared with T2D patients in the never hospitalized 
group.[118] For T2D, the hospitalization rate for men was about 16% higher than for 
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women.[33] Socioeconomic effects of higher education, as well as individual income, 
were important factors that affected disparities in T2D related hospitalization.[119] An 
inverse gradient between income level and T2D related hospitalizations was observed. 
Individuals with T2D in the lowest income quintile were 44% more likely to be 
hospitalized compared to those in the highest quintile (16.4% versus 11.4%).[120] The 
relationship between income and T2D related hospitalizations persisted after adjusting for 
age, sex, comorbidity, frequency of physician visits, continuity of care, physician 
specialty and geographic region.[120] Socioeconomic advantage increased the 
hospitalization rate in both men and women alike.[121] 
The proportion of patients hospitalized for T2D related complications increased with 
age.[118] Furthermore, there is evidence to suggest the adjusted odds of hospitalization 
for both males and females follows a parabolic path.[122] The relationship is such that, 
among adults with T2D, the odds of hospitalization decreased with age until 60 years old 
and then increased with advancing age.[122] Furthermore, a Canadian study examined 
the hospitalization rate for individuals with T2D and found higher hospitalization rates 
among those who were older; around 34% of participants with T2D were aged 65 or 
older when hospitalized, compared with 12% of those aged 14 to 44.[123] 
An individuals’ BMI can also influence T2D related hospitalization with studies 
suggesting that both underweight and overweight, compared to normal weight, can 
increase hospitalization risk. For example, more than half (52%) of the patients with T2D 
related complications had a BMI lower than 24.[118] A Canadian study found that, men 
(OR=1.24) and women (OR=1.25) who were overweight were at an increased risk for 
general hospitalization compared to their counterparts with a normal weight.[124] 
Participants with obesity had a higher risk of hospitalization: Hazard Ratio (HR)=1.82 for 
those aged 25 to 44 years, HR=1.29 for those aged 45 to 64 years, and HR=1.46 for those 
65 years and older.[125] 
A study from Alberta, Canada found First Nations adults had almost four times the odds 
of having a potentially preventable hospitalization or emergency department visit for 
T2D compared to non-First Nations adults.[122] The rate of preventable hospitalizations 
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among urban Métis adults was found to be twice that of non-Indigenous adults.[126] 
Even when demographic, geographic and socioeconomic characteristics were taken into 
account, Métis had 1.5 higher odds of preventable hospitalization, overall.[126] Most 
commonly, these hospitalizations were for T2D or chronic obstructive pulmonary 
disease.[126] Among persons aged 35 years or older, Indigenous men were twice as 
likely to be hospitalized for T2D related illness compared to their non-Indigenous 
counterparts.[127]  
Another Canadian study found, after accounting for differences in service use, that 
individuals living in rural areas of Ontario Canada were up to 1.8 times more likely to 
visit an emergency department or be admitted to a hospital for management of T2D than 
those living in urban communities.[44] Furthermore, those residing in remote areas of the 
province were nearly three times as likely to suffer from preventable hospitalizations.[44] 
More remote, northern areas had higher rates of admission for hypoglycemia and 
emergency department visits for T2D throughout the period of study but experienced 
comparable, or even greater declines in rates, as areas in southern Ontario.[44] 
A study from the Canadian province of Alberta found that limited or increased use of 
primary care among diabetic patients was associated with increased risk of a subsequent 
hospitalization.[128] Compared to patients with 1 to 4 primary care visits, patients with 
no visits to a primary care physician and those with 5 to 9 visits were 11% and 6% more 
likely to experience a subsequent hospitalization, respectively.[128] This study concluded 
that those who visited primary care too much or too little were more likely to have a 
hospitalizations.[128] This may be because those with worse health use primary care 
services more frequently. Additionally, not using primary care service can lead to 
worsening of T2D related complications. In contrast, another Canadian study concluded 
that primary care use may not be a significant predictor of subsequent hospitalization 
among individuals with T2D; those who consulted with a family doctor in the past 12 
months had equal hospitalization rates (24%) to those who did not consult a family doctor 
in the past 12 months (24%).[123] 
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Modifiable health behaviours such as smoking, drinking alcohol, physical activity and 
diet have also been associated with T2D hospitalization events. An Australian study 
found an increased risk of hospital admissions in smokers and physically inactive 
patients.[129] Those who never smoked were less likely than former or current smokers 
to be hospitalized (19%, 27% and 25%, respectively).[123] In contrast, regular alcohol 
drinkers had lower hospitalization rates than those who drank occasionally or were non-
drinkers.[123] Lastly, increased fruit and vegetable consumption has been associated with 
a decrease in BMI and subsequent hospitalization.[130] 
2.7 Undiagnosed type 2 diabetes detected in hospital  
Several studies have been conducted to estimate the prevalence of T2D in a hospital 
setting among previously undiagnosed T2D patients. In the US, a prospective cohort 
study aimed to estimate the percentage of T2D cases in a hospital setting among 
previously undiagnosed patients. Of the 508 patients admitted to the hospital emergency 
department, 50 (9.8%) patients had an admission plasma glucose value in the T2D range. 
The authors were able to conduct secondary confirmatory tests upon discharge in 70% of 
the participants; 60% of these patients were diagnosed with T2D.[40] Another study, in 
the US, used A1C test in emergency department to measure the rate of undiagnosed T2D 
among patients with acute illness. They found previously undiagnosed T2D in 9% of 
patients.[39] Of those aged 45 years and older, 70% had newly diagnosed dysglycemia, 
while 55% of those aged 30 to 44 years were found to have newly diagnosed 
dysglycemia. Of those aged 18 to 29 years, 33% were newly diagnosed with 
dysglycemia. Furthermore, researchers in Germany estimated the prevalence of T2D in 
patients (55 years of age and older) who were admitted to the hospital using A1C test. Of 
the 5820 patients registered, 32.7% had a known history of T2D, whereas 9.5% had 
previously undiagnosed T2D. Patients with previously undiagnosed T2D were admitted 
to hospital predominantly for cardiac disorders (21.9%), nervous system disorders such 
as cerebral infarction (15.0%), and infections/infestations (13.4%).[42]  
Other studies have looked at the prevalence of undiagnosed T2D among patients 
presenting to the hospital with chronic conditions such as heart disease, stroke and kidney 
disease. Patients hospitalized with acute heart failure had a 27.9% prevalence of T2D, 
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half of which were previously undiagnosed.[131] Another study found that the 
prevalence of T2D was 62% in patients with heart issues, of which 40% had diagnosed 
T2D and 22% had undiagnosed T2D.[132] In acute stroke patients, almost two-thirds 
were classified as having T2D; 21% had diagnosed T2D, 15% had undiagnosed T2D, and 
27% had pre-T2D at a 12 week follow-up.[133] In patients with acute coronary heart 
disease, the prevalence of T2D was 48.4%, of which 31.8% had known history of T2D 
and 16.6% had newly diagnosed T2D.[134] Lastly, amongst patients diagnosed with 
chronic kidney disease – after adjusting for age, sex, and ethnicity – 32.9% had 
diagnosed T2D, 24.2% undiagnosed T2D, and 17.1% had pre-T2D.[135] These studies 
demonstrate that a significant portion of patients with chronic illness have undiagnosed 
and therefore untreated T2D. This can be detrimental for the overall health and recovery 
of the patients.  
2.8 Summary 
Diabetes can have profound impacts on patients as well as our healthcare system. Some 
patients with T2D may go undiagnosed and untreated, which may lead to complications 
including hospitalization. However, there remains limited research of Canadians with 
undiagnosed T2D. While a decline in the percentage of T2D hospitalizations has been 
observed until 2011 in Canada, no Canadian literature exists on how the percentage of 
T2D hospitalizations among undiagnosed T2D patients has changed over time. It is also 
important to study the factors associated with undiagnosed T2D requiring hospitalization 
and whether these determinants differ for males and females.  
The overall objective of this thesis is to investigate the percentage of Canadian men and 
women who report no previous T2D diagnosis and whom experience a T2D related 
hospitalization. Specifically, there are three objectives: 
Objective 1: Identify the percentage of men and women in Canada who report no 
previous T2D and experience a T2D related hospitalization.  
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Hypothesis: The percentage of individuals with unreported T2D has been estimated to be 
1.13%-3.09% of general population with men at higher risk.[80] It is hypothesized that 
T2D hospitalizations will be higher among men compared to women.  
Objective 2: Explore temporal trends of T2D related hospitalizations among Canadian 
men and women with unreported T2D. 
Hypothesis: With increasing rates of obesity observed in Canada,[92,93] incidence of 
new T2D might also increase. Which can lead to no change observed in the crude 
prevalence of T2D despite the increase in detection rate. It is hypothesized that that 
percentage of T2D related hospitalizations among unreported T2D patients will remain 
constant for both men and women.  
Objective 3: Explore the role of sociodemographic, health-related and behavioural 
predictors associated with T2D related hospitalization among Canadian men and women 
with unreported T2D.  
Hypothesis: The factors previously associated with T2D related hospitalization will be 
associated with unreported T2D hospitalization. These factors include age, visible 
minority, marital status, education, income, household size, rurality, BMI, self-reported 
health, having a regular doctor, visiting doctor in past 12 months, alcohol drinking, 
smoking tobacco, physical activity, and fruits and vegetable consumption. The risk 




Chapter 3  
3 Methods 
This chapter will first describe in detail the datasets used for this project: Canadian 
Community Health Survey and Discharge Abstract Database. The target population and 
data collection methods will be summarized for each database. This linkage process will 
also be explained. Additionally, this chapter will explain how the outcome variable and 
the explanatory variables are constructed. Lastly, this chapter will lay out the analysis for 
each objective of this thesis. 
3.1 Linked datasets 
In 2012, Statistics Canada approved the linkage of the Canadian Community Health 
Survey (CCHS) 2000-2011 to the Discharge Abstract Database (DAD) 1999-2012.[136] 
The purpose of this record linkage was to better understand and quantify the association 
between behavioural, socio-economic, environmental risk factors, hospitalizations and 
health outcomes at the individual and population level.[136] The DAD and the CCHS are 
complementary sources of data. The DAD contains information on diagnosis and 
intervention for each hospitalization event; however, the DAD does not contain 
information on determinants of health, such as socioeconomic and lifestyle factors.[136] 
Alternatively, the CCHS contains a rich source of information on health status and 
determinants of health, but lacks the detail needed to study hospitalization events.[136] 
Linking the DAD with the CCHS enables a more comprehensive understanding of what 
brings Canadians in contact with acute care facilities.[136] Statistics Canada ensures 
respondent privacy during linkage and subsequent analysis of linked files.[136] Only 
employees directly involved in the linkage process can access the identifying 
information.[136] 
3.1.1 Canadian Community Health Survey 
The CCHS is a cross-sectional survey that collects information related to health status, 
health care utilization and health determinants for the Canadian population.[137] Data 
collection for the survey began in 2000 and was repeated every two years.[137] Starting 
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in 2007, data for the CCHS were collected annually instead of every two years.[137] 
While a sample of approximately 130,000 respondents were interviewed during the 
survey cycles 1.1, 2.1 and 3.1, the sample size was changed to approximately 65,000 
respondents each year starting in 2007.[137] 
3.1.1.1 Population 
The CCHS covers the population 12 years of age and over living in the ten provinces and 
the three territories.[137] Excluded from the survey's coverage are: persons living on 
reserves and other Aboriginal settlements in the provinces, full-time members of the 
Canadian Forces, the institutionalized population, children aged 12 to 17 living in foster 
care, and persons living in the Quebec health regions of Région du Nunavik and Région 
des Terres-Cries-de-la-Baie-James.[137] Altogether, these exclusions represented less 
than 3% of the Canadian population aged 12 and over.[137] The CCHS respondents who 
consented to share and link their survey information with provincial and federal health 
ministries were eligible for linkage. Approximately 84.7% of respondents living outside 
of Quebec agreed to share and link their data.[136] 
3.1.1.2 Data collection 
Before data collection begins for the CCHS, a sample size is calculated to provide 
reliable estimates at the provincial and health region (HR) level.[138] It also takes into 
account any non-response and vacant or out of scope households.[138] First, the sample 
is allocated among provinces proportional to their size and the number of HRs in each 
province.[138] Each province's sample is then allocated among its HRs proportionally to 
the square root of the population in each HR.[138] Data collection for the CCHS is done 
over the telephone or in person, by either computer assisted personal or computer assisted 
telephone interviewing techniques.[137] The interview lasts approximately 45 
minutes.[137] The CCHS response rate ranged from 73% to 85% during data collection 
period of 2001 to 2009.[139,140] 
To ensure better coverage of the target population, two sampling frames are used: an area 
frame and a telephone frame.[138] The area frame is an adaption of the Canadian Labour 
Force Survey which uses a multistage stratified cluster design.[138] The sample is taken 
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through a three-stage sampling process (illustrated in Figure 3.1). First, using geographic, 
economic, and demographic information, the entire country is divided into strata.[138] 
Each stratum is divided into clusters, which is the primary sampling units. The first stage 
of the sample process consists of the selection of these clusters within each stratum.[138] 
In the second stage of sampling, within each selected cluster, a sample of households is 
drawn from a list.[138] The third stage of sampling is the selection of individuals within a 
selected household.[138] Either one or two people are selected depending on the 
household composition; two persons are selected from large households containing 
members in the 12 to 19 years old age group.[138]  
 
Figure 3.1: Illustration of CCHS sampling method 
In some HRs, a Random Digit Dialing (RDD) sampling frame or a list frame of telephone 
numbers was used. The telephone frame originally consisted of RDD frame of telephone 
numbers.[138] This method involved section of working telephone bank (area code and 
the first 5 digits of the telephone number).[138] Then numbers from 00 to 99 were 
generated at random to create a complete phone number.[138] However, due to low hit 
rates, a list frame was used which consisted of a simple list of phone numbers.[141] 
Conversely, the disadvantages of the list frame were: confidential and unlisted numbers 
were missing, and the list can quickly be outdated as people move. However, it increased 
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the hit rates significantly.[141] In the first CCHS cycle, 83% of sample household came 
from an area frame. Approximately, 7% of the sample of households came from the RDD 
frame, while 10% of the sample was generated from the list frame. This changed to 49%, 
50% and 1% of the sample coming from area frame, RDD, and list frame, respectively, in 
the following cycles.[142,143] 
3.1.2 Discharge Abstract Database 
The DAD is a national Canadian database created by the CIHI.[144] This database 
includes all separations from hospitals (including discharge, death, sign-outs and transfer) 
that occur during a fiscal year (April 1 to March 31).[144] Each abstract includes 
information on diagnostic codes, intervention provided and patient demographic and 
administrative information.[144] Data from Quebec are not included in the DAD.[144] 
3.1.2.1 International Statistical Classification of Diseases and 
Related Health Problems 
The DAD uses the International Statistical Classification of Diseases and Related Health 
Problems (ICD) to report diagnosis. The ICD is a coding system for reporting disease and 
health conditions.[144] It was developed by the World Health Organization and was 
endorsed by the world health assembly in 1990.[145] The International Classification of 
Diseases, 9th Revision, Clinical Modification (ICD-9-CM)[146] and the International 
Statistical Classification of Diseases and Related Health Problems, 10th Revision, 
Canada (ICD-10-CA) are enhanced version of the 9th and 10th revision of ICD 
appropriate for Canadian use.[147] In 2001–2002, the format of the DAD abstract was 
changed to accommodate the adoption of the ICD-10-CA classification systems in some 
provinces and territories; before which ICD-9-CM was used.[144] The coding system 
was updated as the ICD-9 was no longer descriptive enough to precisely reflect the state 
of patients’ diseases. For instance, the ICD-9 system had 13,000, three to five-digit codes 
and did not have the capacity to expand.[148] The ICD-10 system has 68,000 codes that 
are three to seven digits each and has the capacity to expand.[148] Since 2004–2005, all 
provinces and territories submitted data to CIHI using the ICD-10-CA abstract.[144] 
Table 3.1 shows the implementation year of ICD-10-CA by each province and 
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territory.[144] When performing analyses over time or across provinces and territories, 
users should note that data element specifications have changed between fiscal years and 
appropriate coding scheme should be used.  
Table 3.1: The year of Implementation of ICD-10-CA by Province and Territories 
Province/ 





















































































































Que. ICD-9-CCP ICD-9-CCP ICD-9-CCP ICD-9-CCP 
ICD-10-
CA/CCI 
The ICD-9-CM diagnosis codes are composed of codes with three, four, or five digits. 
The first three digits are included as the heading of a category of codes that may be 
further subdivided.[149] Diabetes codes fall under the category 250.[149] The fourth 
digit identify complications/manifestations associated with diabetes.[149] See Table 3.2 
for details on how diabetes complications/manifestations are categorized in the fourth 
digit.[149] A fifth digit is required for all category 250 codes to identify the type of 
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diabetes and whether the diabetes is controlled or uncontrolled.[149] See Table 3.3 for 
details on the categorization of diabetes types in the fifth digit.[149] Diabetic conditions 
can be assigned additional codes for associated conditions. In this case, the code from 
category 250 is sequenced before the codes for the associated conditions.[149] Secondary 
codes include diabetic retinopathy (362.0) and diabetic macular edema (362.07); 
however, these codes are coupled with codes from category 250.[149]  
Table 3.2: ICD-9-CM codes for diabetes complications/manifestations 
Description ICD-9-CM code 
Diabetes without mention of complications 250.0X 
Diabetes with ketoacidosis 250.1X 
Diabetes with hyperosmolarity 250.2X 
Diabetes with other coma 250.3X 
Diabetes with renal manifestations 250.4X 
Diabetes with ophthalmic manifestations 250.5X 
Diabetes with neurological manifestation 250.6X 
Diabetes with peripheral circulatory disorders 250.7X 
Diabetes with other specified manifestations 250.8X 
Diabetes with unspecified complications 250.9X 
Table 3.3: ICD-9-CM codes for type of diabetes  
Description ICD-9-CM code  
Type 2 diabetes – not stated as uncontrolled 250.X0  
Type 1 diabetes – not stated as uncontrolled  250.X1 
Type 2 diabetes – uncontrolled 250.X2 
Type 1 diabetes – uncontrolled 250.X3 
In general, ICD-10-CA codes can be up to seven characters long and are designed as 
follows: XXX.XXX.X (category.anatomic site/severity.extension).[148] The first level of 
categorization is the type of diabetes (see Table 3.4).[148] Then the level of control is 
indicated by the number after the decimal point.[148] Each numerical code after the 
decimal point, numbering 1 through 9, describes a different complication (see Table 





Table 3.4: ICD-10-CA codes for type of diabetes  
Description ICD-10-CA code 
Diabetes mellitus due to underlying condition.  
* This code is for diabetes caused by diseases such as 
cancer, pancreatitis, or nutritional deficiencies 
E08.XXX 
Drug or chemical induced diabetes mellitus E09.XXX 
Type 1 diabetes mellitus E10.XXX 
Type 2 diabetes mellitus E11.XXX 
Other specified diabetes mellitus.  
* This code is for genetic defects of β-cell function and 
insulin action or post-pancreatectomy diabetes 
E13.XXX 
Unspecified diabetes E14.XXX 
Table 3.5: ICD-10-CA codes for diabetes complications 
Description ICD-10-CA code 
Type 2 diabetes with coma E11.0XX 
Type 2 diabetes with ketoacidosis E11.1XX 
Type 2 diabetes with renal complications E11.2XX 
Type 2 diabetes with ophthalmic complications E11.3XX 
Type 2 diabetes with neurological complications E11.4XX 
Type 2 diabetes with peripheral circulatory complications E11.5XX 
Type 2 diabetes with other specified complications E11.6XX 
Type 2 diabetes with multiple complications E11.7XX 
Type 2 diabetes with unspecified complications E11.8XX 
Type 2 diabetes without complications E11.9XX 
3.1.2.2 Population  
Approximately 75% of all hospital separations are represented in the DAD.[144] 
Quebec’s hospital separations are submitted to CIHI via Quebec’s ministère de la Santé 
et des Services sociaux once per year and is included in the Hospital Morbidity Database 
(HMDB), but not in the DAD; this usually accounts for 25% of total hospital 
separations.[144] The DAD contains record of hospital activity that is completed for each 
event of a hospital separation, meaning that a patient can have multiple records.[144] 
3.1.2.3 Data collection 
The DAD collection process works as such: first, a patient presents to an acute care 
facility, information is then collected on the patient and necessary diagnosis and 
interventions are made by the health care team, the information is recorded in the 
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institutional health record system, and this information is then submitted to the CIHI 
annually.[144] The data goes through quality control measures to ensure that it is in the 
expected format, falls within a set range; errors are flagged, and missing data is 
represented via blanks or numerical values.[144] Hospitals may be asked to submit 
corrections.[144] Every year, enhancements are made to the database to address 
emerging health care issues, address client needs, and improve data quality.[144] Support 
is provided by the CIHI to assign data collectors with questions related to the DAD 
products and provide educational programs on coding and abstracting, how to manage 
submission errors and corrections, and other related topics.[144] Adherence to the data 
submission and abstracting standards described in the manual helps to ensure that the 
DAD reports accurately reflect the institution’s activities.[144] Adherence is obtained 
through the application quality control edits, education sessions and ongoing client 
support.[144] If data is not received from a particular institution, that institution is 
contacted by the CIHI, if necessary.[144] 
3.2 Linking the Canadian Community Health Survey to the 
Discharge Abstract Database 
There are two types of linkage methods: deterministic and probabilistic.[150] 
Deterministic linkage is the process of linking datasets using an identifier that is unique 
to each participant.[150] There are two possible outcomes of deterministic linkage: 1) 
participants who are an exact match are linked, and 2) unmatched participants who do not 
get linked.[150] In contrast, probabilistic linkage uses multiple, possibly non-unique, 
identifiers to link datasets.[150] Probabilistic record linkage requires the creation of a file 
which compares all records in one dataset with those in the other dataset.[150] Following 
the linkage, an agreement pattern is determined for each comparison and there may be 
partial or full agreement on the identifiers selected for linkage.[150] 
The theory of probabilistic record linkage works on the principle that, when two records 
are compared, the results of certain agreement patterns are representative of truly linked 
pairs, while other agreement patterns are representative of truly unlinked pairs.[150] A 
numerical value is assigned to reflect the agreement of the two records, which is derived 
using conditional probabilities.[150] For the CCHS-DAD linkage file, which uses 
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probabilistic linkage, this numerical value was a weight based on the ratio of the 
estimated probability of the outcome occurring for true matches, to the estimated 
probability of the outcome occurring for non-matches.[151] Researchers then set a 
threshold for determining the linkage status of any two comparisons.[150] 
The CCHS records were linked to hospitalization records using probabilistic methods 
based on the following common identifiers: date of birth, postal code, sex, province and 
Health Insurance Number (HIN).[151] The CCHS file was first linked to the tax data file 
(HSTF).[151] This allowed researchers to identify respondents having more than one 
postal code during 1996-2012.[151] Eligible CCHS respondents who agreed to share 
their data (84.7% = 564,676) were then linked to 49,098,733 hospital records between 
April 1, 1999 through March 31, 2013.[151] A total of 1,188,537 hospitalizations were 
linked to CCHS respondents. Overall, 57.5% of CCHS respondents were linked to at least 
one hospital record.[151]  
False Positive Rate (FPR) and False Negative Rate (FNR) were calculated for the 
linkage.[151] A clerical review of a probabilistic sample of 4,590 record-pairs was 
examined by three independent reviewers.[151] The links are reviewed, and a decision 
was made to accept or reject the pair as definitive.[151] For each pair, the review was 
based on the comparison of date of birth, postal code, sex, province and HIN.[151] The 
final clerical decision was based on the majority vote.[151] The FPR was 0.06% and the 
FNR was 2.09%.[151] 
3.3 Data setup 
The population of interest for this study was individuals who at the time of the CCHS 
interview reported no previous diagnosis of T2D, who were 18 years of age and older, 
were not pregnant at the time of the interview, resided outside Quebec, and were not 
proxy interviews. For the purpose of this project, six cohorts of CCHS respondents who 
met the inclusion and exclusion criteria (CCHS 1.1 [2000 to 2001], CCHS 2.1 [2003 to 
2004], CCHS 3.1 [2005 to 2006], CCHS 2007, CCHS 2008 and CCHS 2009) were 
followed forward in time in the DAD from the date of the CCHS interview. To achieve 
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this, each CCHS cohort was linked to subsequent years of DAD files using unique 
identifiers provided by Statistics Canada.  
Each respondent was followed for three years in the DAD starting from the CCHS 
interview date. An assumption was made that if a CCHS respondent reported no 
diagnosis of T2D at the time of their CCHS interview and was hospitalized within three 
years for a T2D related condition, it is likely they had undiagnosed T2D when the CCHS 
interview was conducted. A three-year follow-up period was chosen as the best 
compromise between diabetes development and progression, and the longest time we can 
assume an individuals had diabetes before diagnosis. Also, the assumption was made that 
self-reporting undiagnosed diabetes is an accurate measure of undiagnosed diabetes. 
Only the first T2D related hospitalization event was considered for this study. Figure 3.2 
illustrates how respondents in the CCHS followed for three years can either have single 
hospitalization events (respondents G and I), multiple hospitalization events (respondents 
A, C, E, L), or no hospitalization events (respondents B, D, F, J, K). These hospitalization 
events can be for different health conditions, including T2D.  
 
Figure 3.2: Illustration of multiple hospitalizations 
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A hospitalization event can lead to several diagnoses. For instance, a person might be 
hospitalized for a hip fracture (primary diagnosis) might also be diagnosed with T2D and 
high blood pressure as a secondary diagnosis. Up to 25 diagnostic codes can be entered 
per hospitalization event. For the purpose of this study, a hospitalization with at least one 
ICD code for diabetes, appearing as any of the 25 diagnostic codes, was considered a 
T2D related hospitalization. Therefore, diabetes might have not be the primary reason for 
hospitalization.  
Respondents from the province of Quebec were removed. Any CCHS respondents who at 
the time of survey reported having diabetes were also removed. Only respondents 18 
years of age and older were included in the study. The reason for limiting the study to this 
age group is that the effects of health behaviours on health-related outcomes may 
manifest differently in adolescents and adults (see objective #3).[152–155] Furthermore, 
the population was limited to non-pregnant individuals. CCHS respondents whose data 
were collected by proxy interviews were excluded due to a low reliability for questions 
regarding health behaviours asked by proxy, as demonstrated in previous research.[156] 
Figure 3.3 illustrates the change in sample size of the linked CCHS-DAD datafile as each 
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Figure 3.3: Inclusion and exclusion criteria – remaining sample size by cohort 
 
As displayed in Figure 3.4, an initial combined sample of 1,137,850 was obtained after 
linking the DAD files to each of the six CCHS cohort. As only the first T2D related 
hospitalization record was used, this resulted in the removal of 621, 535 records or 
54.62% of the sample size. Another 182,595 records were removed due to other 
exclusion criteria (see Figure 3.4). A total of 333,720 of the CCHS respondents met the 
inclusion criteria (i.e., had no previous diagnosis of T2D, were 18 years or older, were 
not pregnant at the time of the interview, resided outside Quebec, were not proxy 
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3.4 Missing data 
Missing data can be divided into three categories. First, values missing completely at 
random (MCAR) are not associated with the values of other variables or the missing 
values itself.[157] Estimated parameters are not biased by this type of missing 
pattern.[157] Second, missing at random (MAR) is the probability that the missing values 
are associated with the observed values, but are not related to the specific missing 
values.[157] Lastly, missing not at random (MNAR) can bias parameter estimates and 
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can occur for two possible reasons: 1) missing values depend on the missing values 
itself;[157] for example, people who have higher income are less likely to report it, or 2) 
missing values are dependent on other variables;[157] for example, females do not want 
to disclose their body weight, therefore, the value of weight is impacted by sex.[157] 
Missing values are generated due to non-response to some or all questions in the 
CCHS.[158] Some reasons for non-response in the CCHS include refusal to answer some 
or all questions, not knowing the answer, and skipping patterns of the questionnaire. In 
addition, some questions might be asked in specific years, or they might be asked only of 
a specific demographic group.[158] There are two types of non-response: total non-
response and partial non-response.[158] Total non-response happens when all variables 
are missing for a person due to complete refusal to participate in the survey or 
interviewers are unable to contact the respondent.[158] This is usually accounted for by 
adjusting the sampling weights at Statistics Canada.[158] Partial non-response is when 
some values are missing for a participant due to refusal to answer specific questions, 
participants not knowing the answers, and unavailability of data due to skipping 
patterns.[158]  
There are multiple approaches to handling partial non-response. For this study, I utilized 
multiple imputation method. In multiple imputation, the missing values are substituted 
with a set of plausible values which contain the natural variability of the right value.[159] 
Missing data is predicated using observed data and the missing values are replaced with 
the predicted value.[159] This process is repeated multiple times creating multiple 
datasets. Each dataset is analyzed separately using standard statistical procedures. The 
analysis results are then combined to produce a single overall estimate.[159] For this 
study, 20 imputations were conducted in order to achieve more consistent estimates and 
standard errors.[160] 
3.5 Measurement 
The outcome variable for this study was T2D related hospitalizations. A number of 
explanatory variables were selected as potential predictors of T2D related hospitalization 
based on previous literature and availability of information in the CCHS. The explanatory 
38 
 
variables selected for comparisons are as follows: age, visible minority, marital status, 
education, income, household size, rurality, BMI, self-reported health, having a regular 
doctor, visiting doctor in past 12 months, alcohol drinking, smoking tobacco, physical 
activity, and fruits and vegetable consumption. The explanatory variables were broken 
down into three groups:  sociodemographic, health-related and behavioural predictors. 
Some categorical variables were collapsed to binary variables. Lastly, survey design 
variables (mode of interview, year of interview) were used to adjust for differing survey 
conditions.  
3.5.1 Outcome variable – type 2 diabetes related hospitalization  
To ascertain T2D related hospitalization amongst individuals with unreported T2D, the 
population of interest was followed in the DAD for three years following their interview 
date. If a diagnosis code for T2D (primary or secondary) occurred during the three-year 
follow-up period, respondents were coded as having T2D related hospitalization. If 
respondents were not hospitalized or were hospitalized for other conditions, they were 
coded as not having T2D related hospitalization.  
The diagnosis codes were based on the ICD-9-CM and ICD-10-CA for T2D due to 
changes in diagnosis coding in the DAD over time. For ICD-9-CM, category 250.X0 and 
250.X2 (X = 0 through 9) were selected. For ICD-10-CA, E11.XXX.X (with any 
anatomic site/severity and extension) were selected. All diagnoses, up to 25 diagnostic 
codes per hospitalization event, were considered. 
3.5.2 Sex 
Sex is a binary variable in the CCHS. Interviewers entered in the sex of the respondent 
during initiation of the interview. If necessary, interviewer asked the sex of the 
participants. This is coded as male and female. No missing values were observed for this 
variable. The analyses were stratified by sex. 
3.5.3 Sociodemographic predictors 
Sociodemographic variables include age, visible minority, marital status, education, 
income, household size and rurality. These variables have been previously linked to T2D 
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or T2D related hospitalization among individuals diagnosed with T2D. For example, the 
proportion of patients hospitalized for T2D related complications has been shown to 
increase with age.[118] Furthermore, there is evidence to suggest the adjusted odds of 
hospitalization for both males and females followed a parabolic path.[122] Additionally, 
non-white individuals[122] and non-married individuals have been found to have higher 
T2D related hospitalizations.[161] Individuals in the lowest income and education 
quintile are more likely to have an a T2D hospitalization event than those in the highest 
quintile.[120] Household size was included to reflect how many individuals in the 
household depend on the income.[162] Lastly, living in rural areas has also shown to 
affect hospitalization events.[44] 
3.5.3.1 Age 
Age is a continuous variable and is based on the CCHS respondents date of birth. For the 
purpose of this study, age was centered at 18 and coded into deciles. The age variable 
was squared and used in the regression model as a quadratic predictor alongside a linear 
age variable. No missing values were observed for this variable. 
3.5.3.2 Visible minority 
In the CCHS, two questions are asked to determine the respondent's visible minority 
status. First respondents are asked, “Are you an Aboriginal person, that is, First Nations, 
Métis or Inuk (Inuit)?”. Non-aboriginal respondents are further asked to classify 
themselves as part of one or more racial or cultural groups on the following list: White, 
South Asian (e.g., East Indian, Pakistani, Sri Lankan etc.), Chinese, Black, Filipino, Latin 
American, Arab, Southeast Asian (e.g., Vietnamese, Cambodian, Malaysian, Laotian, 
etc.), West Asian (e.g., Iranian, Afghan, etc.), Korean and Japanese. For the purpose of 
this study, a binary variable was created. One group was classified as white and visible 
minority, including Aboriginal, were grouped as non-white. Non-respondents were coded 
as missing to be imputed. 
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3.5.3.3 Marital status  
Marital status is a categorical variable in the CCHS. Respondents were asked to classify 
themselves into one of the six categories: married, common-law, widowed, separated, 
divorced and single and never married. For the purpose of this study, this variable was 
dichotomized. Married and common-law were grouped together as married.  Widowed, 
separated, and divorced were group as not married. No missing values were observed for 
this variable. 
3.5.3.4 Education 
The following question was used to determine the level of education achieved by the 
CCHS respondents: “what is the highest degree, certificate or diploma you have 
obtained?” Possible answers included: Less than secondary school graduation, secondary 
school graduation, some post-secondary, post-secondary and graduate. For the purpose 
of this study, a dichotomous variable was created with the following categories: less than 
secondary school and secondary school or more. Non-response was coded as missing to 
be imputed. 
3.5.3.5 Income 
Income was a derived variable based on respondents answer to the question: “What is 
your best estimate of the total income, before taxes and deductions, of all household 
members from all sources in the past 12 months?”. If respondents did not answer the 
question, they were asked to estimate which of the following groups their household 
income fell into: less than $5,000 or $5,000 or more, less than $10,000 or $10,000 or 
more, less than $15,000 or $15,000 or more, less than $20,000 or $20,000 or more, less 
than $30,000 or $30,000 or more, less than $40,000 or $40,000 or more, less than 
$50,000, $50,000 to less than $60,000, $60,000 to less than $80,000, $80,000 to less than 
$100,000, and $100,000 or more.  
The CCHS categorized total household income from the above questions. Possible 
categorizations in CCHS 1.1 were no income, less than $5000, $5000 to $9999, $10,000 
to $14,999, $15,000 to $19,999, $20,000 to $29,999, $30,000 to $39,000, $40,000 to 
41 
 
$49,000, $50,000 to $59,999, $60,000 to $79,999 and $80,000 or more. However, the 
categories were expanded over time to include $60,000 to $69,000, $70,000 to $79,999, 
$80,000 to $89,999, $90,000 to $99,999, $100,000 to $149,999 and $150,000 or more. 
For the purpose of keeping this variable consistent throughout the survey collection 
period, the categorizations were standardized to the CCHS 1.1. Non-response to this 
variable was coded as missing for imputation. 
3.5.3.6 Household size 
The CCHS includes variable that indicates the number of people living within a 
household. This variable was a continuous variable with values ranging from 1 to 28. 
This variable was recoded to include one, two, three, four, five, six or more. There were 
no missing values on this variable. 
3.5.3.7 Rurality 
Respondents in the CCHS were categorized into rural or urban based on their postal 
code. The CCHS described an urban area as continuously built-up and not having 
discontinuity exceeding two kilometers. Urban areas were also categorized as having a 
population concentration of 1,000 or more and a population density of 400 or more per 
square kilometer. This was based on the most recent census information.[163] This 
variable did not have any missing information 
3.5.4 Health-related predictors 
These predictors include BMI and self-reported health. There has a been a strong 
association found between BMI and T2D. Hospitalizations related to T2D have also been 
linked to BMI.[118] Furthermore, T2D can be linked to several other health conditions, 
with worse health status predicting hospitalization events.[123]  
3.5.4.1 Body mass index 
In order to derive BMI, the height and weight of the participants was used. In the CCHS, 
respondents are asked to disclose their height and weight. These values can be expressed 
in either inches or centimeter and pounds or kilograms. All values are converted to metric 
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units by CCHS. The following formula was used to calculate respondents’ BMI: 
BMI=kg/m^2. Any missing values for height or weight generated missing value for BMI. 
This was flagged as missing for imputation purposes.  
3.5.4.2 Self-perceived health 
Respondents were asked, “In general, would you say your health is excellent, very good, 
good, fair, or poor?”. A binary variable was created with excellent, very good, good 
categorized as good and fair or poor categorized into poor. Respondents who did not 
answer this question were flagged and missing values were imputed 
3.5.5 Behavioural predictors  
Behavioural predictors include having a regular doctor, visiting doctor in past 12 months, 
alcohol drinking, smoking tobacco, physical activity, and fruits and vegetable 
consumption. These variables have previously been linked to T2D and T2D 
hospitalization. Increased use of primary care among T2D patients has been associated 
with increased risk of a subsequent hospitalization.[128] Primary care use has also been 
associated with T2D hospitalizations.[123] An increased risk of hospital admissions in 
smokers and physically inactive participants has been found.[129] In contrast, regular 
alcohol drinkers have been shown to have lower hospitalization rates than did occasional 
or non-drinkers.[123] Lastly, eating a diet high in fruits and vegetables has been 
associated with lower hospitalization rates for T2D.[164] 
3.5.5.1 Having a regular doctor 
All respondents in the CCHS were asked, “Do you have a regular medical doctor?” 
Respondents could answer yes or no. Respondents who did not know the answer or 
refused to answer were flagged as missing for imputation. 
3.5.5.2 Visiting doctor in past 12 months 
The CCHS asks respondents, “During the past 12 months, how many times have you seen 
or talked to on the telephone, about your physical, emotional or mental health with a 
family doctor or a general practitioner?” Responses ranged from 0 to 366. For the 
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purpose of this study, this variable was categorized in to visited doctor in past 12 months 
and did not visit doctor in the past 12 months. Non-responses to this question were 
flagged as missing for imputation.  
3.5.5.3 Alcohol drinking 
In the CCHS, respondents were asked the following questions about their drinking 
history: “have you ever had a drink?”; “have you drank in the past 12 months?”; and if 
so, “during the past 12 months, how often did you drink alcoholic beverages?” This 
information was used to derive a categorical variable that groups respondents into the 
following drinking categories: regular drinker, occasional drinker and former drinker, 
and never drank. Regular drinkers are defined as anyone who drinks at least once a 
month. Occasional drinkers are defined as individuals who drink less than once a month. 
Former drinkers consist of individuals who drank in their lifetime but not in the past 12 
months. Lastly, never drank is defined as individuals who have not consumed alcoholic 
beverages in their lifetime.  
For the purpose of this study, a binary variable was created. Regular drinkers and 
occasional drinkers were grouped as current drinkers. Former drinkers and never drank 
were grouped as currently non-drinkers. Respondents who did not answer were flagged 
as missing for imputation. 
3.5.5.4 Smoking tobacco 
In the CCHS, respondents were asked the following questions: 1) “In your lifetime, have 
you smoked a total of 100 or more cigarettes?”; 2) “Have you ever smoked a whole 
cigarette?”; 3) “At the present time do you smoke cigarettes daily, occasionally or not at 
all?; 4) “Have you ever smoked cigarettes daily?” Based on smoking habits, respondents 
were categorized into the following 7 categories: daily smokers, occasionally but former 
daily smoker, always occasional smoker, former daily smoker non-smoker now, former 
occasional smoker nonsmoker now and never smoked.  
A dichotomous variable was created for the purpose of this study. Daily, occasionally but 
former daily smoker, and always occasional smoker were grouped together as current 
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smokers whereas former daily smoker non-smoker now, former occasional smoker non-
smoker now, and never smoked were grouped together as currently non-smokers. 
Respondents who did not answer were flagged as missing.  
3.5.5.5 Physical activity 
Physical activity was measured using participants’ self-reported frequency and duration 
of leisure physical activity within the three months prior to survey administration. In the 
CCHS, each type of physical activity (e.g., swimming, biking) was assigned a 
corresponding Metabolic Equivalent (MET) value - multiple of resting metabolic rate. 
For example, a MET value of 2 indicates twice the energy expended compared to rest. 
The volume of physical activity was calculated by multiplying the frequency and duration 
of each type of physical activity as well as the MET value of the activity to derive how 
much energy was expended daily. Higher MET values indicate higher volume of physical 
activity. Respondents who did not answer were flagged as missing for imputation. 
3.5.5.6 Fruits and vegetable consumptions 
Total fruit and vegetable consumption was based on responses to a series of questions 
regarding the frequency of consumption of specific types of fruits and vegetables. 
Participants were asked the following questions: “how often do you drink fruit juices 
such as orange, grapefruit or tomato?”; “how often do you usually eat fruit?”; “how often 
do you eat green salad?”; “how often do you eat potatoes, not including french-fries, fried 
potatoes, or potato chips?”; “how often do you usually eat carrots?”; “how many servings 
of other vegetables do you usually eat, not counting carrots, potatoes, or salad?” 
Participants could report on per day, per week, or per month bases. Average daily 
frequency of fruit and vegetable consumption was calculated for each participant as a 
continuous measure by first converting the numerical responses into average daily 
consumption and then adding the responses to the six questions. Respondents who did not 
answer were flagged as missing. 
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3.5.6 Survey design variables 
Survey design variables included the year of the CCHS interview and mode of interview. 
As prevalence of T2D, management of T2D and polices around health care changed over 
time in Canada, it is important to consider how the year of data collection can impact 
T2D related hospitalizations. Additionally, when comparing two modes of interviewing, 
in-person interviews to telephone interviews, significant differences were found between 
two modes of interviews for some health indicators.[165] For example, obesity was 
significantly higher for in-person interviews (17.9%) than for telephone interviews 
(13.2%).[165] 
3.5.6.1 Interview date 
The CCHS records the date of the CCHS interview; this includes the day, month and 
year. A new variable was created, year of interview, to represent the year of the data 
collection ranging from 2000 to 2009. This variable was further centered at the year 
2000, the first year of data collection for the first CCHS cohort, which results in the range 
of 0 to 9. The purpose for centering the variable at 2000 was so the intercept term in the 
regression model can be interpreted as the log-odds of T2D related hospitalization when 
the year of data collection is 2000. 
3.5.6.2 Mode of interview 
Mode of interview is a binary variable in the CCHS with in-person interview and 
telephone interview as the two options. Missing information on this variable was flagged 
for imputation 
3.6 Statistical analysis 
This study employed sex gender-based analysis (SGBA),[166] an approach that examines 
diversity between males and females with the goal of contributing to more 
comprehensive knowledge that addresses differences between women and men. Male and 
female bodies have innate physiological differences that may contribute to the 
relationship between explanatory variables and T2D related hospitalization 
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differently.[167] There is research to suggest T2D related hospitalization rate differ 
between men and women.[33]  
3.6.1 Descriptive statistics 
Descriptive statistics were produced for both missing and imputed datasets to understand 
the basic characteristics of the combined six CCHS cohorts. The SURVEYFREQ 
procedure in SAS was used to produce population estimates and frequencies from survey 
data. This procedure utilizes bootstrap weights to takes into account the survey design to 
compute variance and confidence intervals.[168] The SURVEYFREQ procedure in SAS 
was used to compute a frequencies distribution table with 95% confidence intervals for 
nominal and ordinal variables. Frequency distribution was computed for the following 
categorical variables: mode of interview, visible minority, marital status, education, 
income, household size, rurality, self-reported health, having a regular doctor, visiting 
doctor in past 12 months, alcohol drinking, and smoking tobacco. The SURVEYMEANS 
procedure in SAS was used to produce population estimates means, standard deviation 
and corresponding 95% confidence interval (CI) for continuous variables. This procedure 
also estimates variance and confidence intervals taking into account the survey 
design.[169] Means and standard deviations were generated for the following variables: 
age, income, household size, BMI, physical activity, and fruits and vegetable 
consumption.  
3.6.2 Analysis for objective 1 
The first objective is to identify the percentage of men and women in Canada with 
unreported T2D who experience a T2D related hospitalization. Using SURVEYFREQ 
procedures, a frequency distribution table was created for the outcome variable T2D 
related hospitalization separately for males and female. Results were generated by 
pooling respondents from the six CCHS cohorts. This estimated the average percentage 




3.6.3 Analysis for objective 2 
The second objective was to explore temporal trends of T2D related hospitalizations 
among Canadian men and women with unreported T2D. First, SURVEYFREQ 
procedures was used to produce percent of T2D related hospitalizations with 
corresponding confidence intervals for each year the CCHS survey was conducted. A bar 
graph was produced for the percentage of T2D related hospitalization in each year. 
Second, SURVEYLOGISTIC procedure was used to model the log-odds of T2D related 
hospitalizations based on the year of respondents’ interviews. PROC 
SURVEYLOGISTIC fits linear logistic regression models for categorical response by the 
method of maximum likelihood. SURVEYLOGISTIC incorporates complex survey 
designs, including designs with stratification, clustering, and unequal weighting by using 
bootstrap weights. 
3.6.4 Analysis for objective 3 
The third objective was to explore the role of sociodemographic, health and behavioral 
risk factors associated with T2D related hospitalization among Canadian men and women 
with unreported T2D. Using SURVEYLOGISTIC, a linear logistic regression model was 
produced for males and females separately using the imputed datasets. The outcome 
variable was T2D related hospitalization and the explanatory variables were age, marital 
status, visible minority, education, income, household size, rurality, BMI, self-reported 
health, having a regular doctor, visiting doctor in past 12 months, alcohol drinking, 
smoking tobacco, physical activity, and fruit and vegetable consumption. Mode of 
interview and year of interview were included in the model to control for survey 
conditions. MIANALYZE was used to pool the results of each estimates from each 
imputed dataset. Odds ratios and confidence intervals were computed. Statistical 
significance was defined as a p-value < 0.05.  
Mode of interview, visible minority, marital status, education, rurality, self-reported 
health, having a regular doctor, visiting doctor in past 12 months, alcohol drinking and 
smoking tobacco were treated as categorical variables in the logistics regression model. 
The reference groups are presented in Table 3.5. Whereas age, income, household size, 
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BMI, physical activity, and fruits and vegetable consumption were treated as continuous 
variables. 
Table 3.6: Reference group for categorical variables 
Variables Reference Group 
Type of interview Telephone Interview 
Visible minority White 
Marital status Not married 
Education Less than secondary  
Rurality Urban 
Self-reported health Good 
Having a regular doctor No 
Visit doctor in past 12 months No 
Alcohol drinking currently non-drinker 
Smoking tobacco currently non-smoker 
3.6.5 Sampling weights 
The sample weight corresponds to the number of people in the population that are 
represented by each CCHS respondent. Standardized sample weights were applied to all 
statistical tests in order for the estimates produced by this study to be representative of 
Canadian population. Sampling probability differ between regions; therefore, weights are 
different from one person to another.[170] 
3.6.6 Bootstrap weights 
To ensure that results from the analysis of the CCHS data take into account complex 
design, bootstrap weights were used. The bootstrap method consisted of subsampling the 
initial CCHS sample and they were generated at statistics Canada. A simple random 
sample was selected, with replacement, from n-1 clusters within the n clusters of the 
stratum. The process was repeated 500 times, creating 500 new subsamples. Weights 
were recalculated for each of the 500 samples called the bootstrap weights. The bootstrap 
weights were used to calculate 500 estimates which are then used to estimate the 
variance.[171] 
3.6.7 Statistical software 





This chapter will present the study findings. First, this chapter will summarize the 
missing data patterns for variables of interest. Then it will provide a description of the 
study sample. Following that, the results for objective 1, objective 2 and objective 3 will 
be presented.  
4.1 Descriptive statistics 
Of the CCHS respondents included in the study, 45.04% (150,305 respondents) were 
male and 54.96% (183,415 respondents) were female. Overall, 79% of respondents had 
complete data with no missing values for any of the variables included in this study. 
Table 4.1 outlines the missing data pattern for males and females. Percentage of missing 
values was generally low for most variables, with less than 1% missing. Income and fruit 
and vegetable consumption had the highest missing percentage; 8.77% and 9.67%, 
respectively, for males and 12.32% and 9.45%, respectively, for females. Missing 
patterns were similar between males and females except for BMI and smoking status. 
Female respondents had higher percentage of missing values for BMI compared to males 
(3.27% vs. 0.66%). Whereas men had higher percentage of missing values for the 
smoking variable (0.46% vs. 0.14%). When the descriptive statistics for the datasets with 
missing values and the imputed values are compared, the estimates are similar. 
Table 4.1: Descriptive statistics for dataset with missing values 










Mode of interview     
Telephone 61.47 60.60 62.34 61.12 60.21 62.02 
In person 38.53 37.66 39.40 38.88 37.98 39.79 




43.74 43.89 45.6 (17.26) 45.52 45.68 
Visible minority     
White 80.53 80.01 81.04 80.96 80.52 81.40 
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Non-white 19.47 18.96 19.99 19.04 18.60 19.48 
  Percent missing = 0.56 Percent missing = 0.49 
Marital status     
Not married 34.09 33.59 34.60 37.52 37.13 37.91 
Married 65.91 65.40 66.41 62.48 62.09 62.87 
  Percent missing = 0.10 Percent missing = 0.13 
Education     
Less than secondary 
school 
14.60 14.32 14.87 14.46 14.21 14.71 
Secondary school or 
more 
85.40 85.13 85.68 85.54 85.29 85.79 
  Percent missing = 1.08 Percent missing = 0.91 
Income     
No Income 0.34 0.27 0.40 0.27 0.22 0.31 
Less than $5,000   0.51 0.45 0.58 0.57 0.52 0.62 
$5,000 - $9,999   0.99 0.90 1.08 1.49 1.39 1.58 
$10,000 - $14,999  2.37 2.24 2.50 4.26 4.12 4.41 
$15,000 - $19,999  2.41 2.29 2.54 4.35 4.20 4.51 
$20,000 - $29,999  6.91 6.69 7.14 9.66 9.42 9.89 
$30,000 - $39,999  8.61 8.37 8.86 10.26 10.00 10.52 
$40,000 - $49,999  8.89 8.63 9.14 9.45 9.21 9.69 
$50,000 - $59,999  9.14 8.89 9.39 9.31 9.06 9.56 
$60,000 - $79,999  17.53 17.15 17.90 16.49 16.15 16.83 
$80,000 Or More 42.29 41.80 42.78 33.89 33.44 34.34 
Mean Income 8.22 (2.13) 8.19 8.24 7.72 (2.31) 7.70 7.74 
  Percent missing = 8.77 Percent missing = 12.32 
Household size     
1 12.07 11.57 12.58 14.50 14.01 14.96 
2 32.80 32.20 33.39 33.65 33.04 34.18 
3 19.49 19.10 19.88 18.47 18.08 18.83 
4 21.73 21.14 22.32 20.16 19.67 20.61 
5 9.16 8.79 9.52 8.89 8.51 9.25 
6 4.75 4.43 5.08 4.44 4.16 4.71 
Mean Household Size 2.97 (1.35) 2.94 3.01 2.89 (1.36) 2.86 2.91 
Rurality     
Urban 82.06 81.70 82.42 82.93 82.61 83.25 
Rural  17.94 17.58 18.30 17.07 16.75 17.39 
BMI 26.37 (4.42) 26.34 26.41 25.06 (5.20) 25.02 25.10 
  Percent missing = 0.66 Percent missing = 3.27 
Self-reported health     
Poor 9.48 9.23 9.72 11.19 10.92 11.46 
Good 90.52 90.28 90.77 88.81 88.54 89.08 
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  Percent missing = 0.07 Percent missing = 0.08 
Having a regular 
doctor 
    
No 16.16 15.83 16.48 8.42 8.20 8.65 
Yes 83.84 83.52 84.17 91.58 91.35 91.80 
  Percent missing = 0.05 Percent missing = 0.03 
Visit doctor in past 12 
months 
    
No 27.07 26.66 27.47 14.67 14.37 14.97 
Yes 72.93 72.53 73.35 85.33 85.03 85.63 
  Percent missing = 0.21 Percent missing = 0.42 
Alcohol drinking     
Currently non-drinker 14.35 14.01 14.69 22.88 22.48 23.28 
Currently drinker 85.65 85.31 86.00 77.12 76.72 77.52 
  Percent missing = 0.46 Percent missing = 0.42 
Smoking tobacco     
Currently non-smoker 73.65 73.24 74.06 79.47 79.16 79.79 
Currently smoker 26.35 25.94 26.76 20.53 20.21 20.84 
  Percent missing = 0.46 Percent missing = 0.14 
Physical Activity 2.31 (2.44) 2.28 2.33 1.94 (1.94) 1.93 1.96 
  Percent missing = 0.13 Percent missing = 0.08 
Fruit and vegetable 
consumption 
4.43 (2.55) 4.40 4.45 5.11 (2.64) 5.08 5.13 
  Percent missing = 9.67 Percent missing = 9.45 
Note: Proportion and confidence interval are presented for categorical variables: mode of interview, visible 
minority, marital status, education, income, household size, rurality, self-reported health, having a regular 
doctor, visiting doctor in past 12 months, alcohol drinking and smoking tobacco. Mean and standard 
deviation (SD) with corresponding confidence intervals are presented for continuous variables: age, 
income, household size, BMI, physical activity, and fruits and vegetable consumption. 
Table 4.2 summarizes the descriptive statistics for the imputed data. The mean age was 
43.81 (SD=16.42) and 45.60 (SD=17.26) for males and females, respectively. 
Approximately 19% of males and females reported being visible minority, 65.90% of 
males and 62.47% of females reported being married, and approximately 14.60% of 
males and 14.46% of females reported having less than secondary schooling. A higher 
percentage of men reported an income of $80,000 or more compared to women (41.34% 
vs. 32.52). The mean income for men ($50,000-$79,999) was higher than women 
($40,000-$59,999). Household size was similarly distributed between men and women 
with majority of household comprising of 1 to 4 people. The majority of people lived in 
urban centers (~82%). 
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Upon examining the health-related predictors, the mean BMI reported by men was 26.37 
(SD=4.42). The mean BMI reported by women was slightly lower at 25.08 (SD=5.20). 
For self-report health, 9.48% of men and a slightly higher percentage of women (11.20%) 
reported having poor health.  
For the behavioural predictors, 83.84% of men and 91.58% of women reported having 
regular doctors, and 72.99% of men and 85.10% of women reported visiting a doctor in 
the past 12 months. A higher percentage of men reported being current drinkers 
compared to women (85.62% vs. 77.70%). Additionally, a higher percentage of men 
reported being current smokers compared to women (26.34 vs. 20.53). Men had higher 
levels of physical activity compared to women; mean MET for men was 2.31 (SD=2.44), 
whereas, mean MET for women was 1.95 (SD=2.04). Lastly, women reported a higher 
percentage of fruit and vegetable consumption; mean fruit and vegetable consumption for 
females was 5.11 (SD=2.57) and mean fruit and vegetable consumption for men was 4.43 
(SD=2.28).  
Table 4.2: Descriptive statistics for dataset with imputed values 










Mode of Interview     
Telephone 61.48 60.61 62.35 61.12 60.22 62.03 








Visible minority     
White 80.53 80.02 81.04 80.97 80.53 81.40 
Non-white 19.47 18.96 19.98 19.03 18.60 19.47 
Marital status     
Not married 34.10 33.60 34.60 37.53 37.14 37.91 
Married 65.90 65.40 66.40 62.47 62.09 62.86 
Education     
Less than secondary 
school 
14.66 14.38 14.93 14.53 14.28 14.78 
Secondary school or 
more 
85.34 85.07 85.62 85.47 85.22 85.72 
Income     
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No Income 0.31 0.25 0.36 0.26 0.22 0.30 
Less Than $5,000   0.49 0.43 0.55 0.57 0.53 0.62 
$5,000 - $9,999   0.97 0.90 1.05 1.53 1.45 1.62 
$10,000 - $14,999  2.45 2.34 2.56 4.42 4.29 4.55 
$15,000 - $19,999  2.54 2.43 2.65 4.50 4.37 4.64 
$20,000 - $29,999  7.14 6.93 7.34 10.02 9.82 10.22 
$30,000 - $39,999  8.87 8.65 9.09 10.62 10.40 10.84 
$40,000 - $49,999  9.05 8.83 9.27 9.70 9.49 9.90 
$50,000 - $59,999  9.30 9.08 9.52 9.44 9.23 9.66 
$60,000 - $79,999  17.55 17.21 17.88 16.41 16.11 16.71 
$80,000 Or More 41.34 40.89 41.79 32.52 32.13 32.90 
Mean Income 8.18 (2.17) 8.17 8.19 7.66 (2.36) 7.64 7.68 
Household size     
1 12.07 11.57 12.58 14.48 14.01 14.96 
2 32.80 32.20 33.39 33.61 33.04 34.18 
3 19.49 19.10 19.88 18.45 18.08 18.83 
4 21.73 21.14 22.32 20.14 19.67 20.61 
5 9.16 8.79 9.52 8.88 8.51 9.25 
6 4.75 4.43 5.08 4.43 4.16 4.71 
Mean Household size 2.98 (1.35) 2.95 3.01 2.89 (1.36) 2.86 2.92 
Rurality     
Urban 82.06 81.70 82.42 82.93 82.61 83.25 
Rural  17.94 17.58 18.30 17.07 16.75 17.39 
BMI 26.37 (4.42) 26.34 26.41 25.08 (5.20) 25.04 25.12 
Self-reported health     
Poor 9.48 9.23 9.73 11.20 10.93 11.47 
Good 90.52 90.27 90.77 88.80 88.53 89.07 
Having a regular 
doctor 
    
No 16.16 15.84 16.48 8.42 8.20 8.65 
Yes 83.84 83.52 84.16 91.58 91.35 91.80 
Visit doctor in past 
12 months 
    
No 27.01 26.60 27.42 14.60 14.30 14.90 
Yes 72.99 72.58 73.40 85.40 85.10 85.70 
Alcohol drinking     
Currently non-drinker 14.38 14.04 14.72 22.90 22.50 23.30 
Currently drinker 85.62 85.28 85.96 77.10 76.70 77.50 
Smoking     
Currently non-smoker 73.66 73.25 74.06 79.47 79.16 79.79 
Currently smoker 26.34 25.94 26.75 20.53 20.21 20.84 
Physical activity 2.31 (2.44) 2.28 2.33 1.95 (2.04) 1.93 1.96 
54 
 
Fruit and vegetable 
consumption 
4.43 (2.48) 4.40 4.45 5.11 (2.57) 5.08 5.13 
Note: Proportion and confidence interval are presented for categorical variables: mode of interview, visible 
minority, marital status, education, income, household size, rurality, self-reported health, having a regular 
doctor, visiting doctor in past 12 months, alcohol drinking and smoking. Mean and standard deviation (SD) 
with corresponding confidence intervals are presented for continuous variables: age, income, household 
size, BMI, physical activity, and fruits and vegetable consumption. 
4.2 Objective 1 
Among Canadian adults with unreported T2D, 0.56% (95% CI=0.49%, 0.63%) of men 
and 0.44% (95% CI=0.39%, 0.48%) of women experienced a hospitalization event 
related to T2D during 2000-2009. That is 840 men and 800 women who were 
hospitalized for T2D up to three years following the CCHS interview but reported no 
previous diagnosis of diabetes. The percentage hospitalization event related to T2D was 
higher among men than in women.  
Table 4.3: Percentage of type 2 diabetes related hospitalization among adults with 
unreported diabetes 
 Male (n = 150,305) Female (n = 183,415) 






No 99.44 99.37 99.51 99.56 99.52 99.61 
Yes 0.56 0.49 0.63 0.44 0.39 0.48 
4.3 Objective 2 
Among Canadian adults with unreported T2D, 0.44% (95% CI=0.27%, 0.55%) of men 
and 0.33% (95% CI=0.23%, 0.43%) of women experienced a hospitalization event 
related to T2D in 2000. Among men, an increase in the percentage of T2D related 
hospitalizations was observed in 2001 (0.47%; 95% CI=0.36%, 0.59%). Hospitalizations 
declined in 2003 to 0.43% (95% CI=0.34%, 0.50%); however, the percentage of men 
experiencing T2D related hospitalization steadily increased after that: 0.49% (95% 
CI=0.57%, 0.99%) in 2005; 0.55% (95% CI=0.42%, 0.67%) in 2007; 0.65% (95% 
CI=0.42%, 0.88%) in 2008; 0.77% (95% CI=0.54%, 0.99%) in 2009. In contrast, among 
women, an increase in the percentage of T2D related hospitalization was observed till 
2005 (0.52%; 95% CI=0.42%, 0.63%). However, the percentage declines to 0.37% (95% 
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CI=0.27%, 0.47%) in 2007. A further increase was observed after that: 0.40% (95% 
CI=0.25%, 0.50%) in 2008; 0.55% (95% CI=0.41%, 0.68%) in 2009. (Table 4.4) 
Table 4.4: Temporal trend in percentage of type 2 diabetes related hospitalization 
between 2000 to 2009 among adults with unreported type 2 diabetes 









2000 0.41 0.27 0.55 0.33 0.23 0.43 
2001 0.47 0.36 0.59 0.37 0.28 0.45 
2003 0.43 0.34 0.50 0.42 0.33 0.49 
2005 0.49 0.40 0.57 0.52 0.42 0.63 
2007 0.55 0.42 0.67 0.37 0.27 0.47 
2008 0.65 0.42 0.88 0.40 0.28 0.50 
2009 0.77 0.54 0.99 0.55 0.41 0.68 
Figure 4.1 and Figure 4.2 illustrate the change in percentage of T2D related 
hospitalization among men and women with unreported T2D, respectively. The linear 
trend was tested and showed that men had higher odds of T2D related hospitalization 
between 2000 and 2009 (OR=1.07, CI=1.03, 1.12). This annual positive trend was a 
statistically significant (p=0.0004). For women, however, the linear trend in T2D related 
hospitalization was not statistically significant (p=0.0987; OR=1.03, CI=0.99, 1.06). 





Figure 4.1: Temporal trends in percentage of type 2 diabetes related hospitalization 




































Figure 4.2: Temporal trends in percentage of type 2 diabetes related hospitalization 
between 2000 to 2009 among females with unreported diabetes  
Table 4.5: Test of linear trend for type 2 diabetes related hospitalization between 
2000 to 2009 among adults with unreported type 2 diabetes 















1.07 1.03 1.12 0.0004* 1.03 0.99 1.06 0.0987 
Note: * denotes significances at alpha=0.05 
4.4 Objective 3 
Examination of the cross tabulation of sociodemographic, health-related, and behavioural 
predictors (see Table 4.6) reveals that a higher percentage of white males (0.59%, 95% 
CI= 0.53%, 0.66%) and white females (0.46%, 95% CI= 0.41%, 0.51%) with unreported 
T2D were hospitalized for T2D between 2000 to 2009 compared to non-white males and 



































respectively). A higher percentage of married men reported T2D related hospitalization 
compared to non-married men (0.42%, 95% CI= 0.36%, 0.49% and 0.63%, 95% CI= 
0.54%, 0.72%, respectively). In contrast, women who were not married reported a higher 
percentage of T2D related hospitalization compared to married women (0.53%, 95% CI= 
0.46%, 0.60% and 0.38%, 95% CI= 0.33%, 0.43%, respectively). Both men and women 
who had less than secondary education reported higher percentage of T2D related 
hospitalization (1.13%, 95% CI= 0.97%, 1.29% and 1.09%, 95% CI= 0.93%, 1.24%, 
respectively) compared to men and women who had secondary school or more (0.46%, 
95% CI= 0.39%, 0.53% and 0.32%, 95% CI= 0.28%, 0.36%, respectively). Both men and 
women who lived in a rural area reported higher percentage of T2D related 
hospitalization (0.53%, 95% CI= 0.46%, 0.61% and 0.41%, 95% CI= 0.37%, 0.46%, 
respectively) compared to men and women who lived in urban area (0.67%, 95% CI= 
0.55%, 0.79% and 0.55%, 95% CI= 0.45%, 0.64%, respectively). Men and women who 
reported poor health reported much higher percentage of T2D related hospitalizations 
(1.95%, 95% CI= 1.67%, 1.24% and 1.28%, 95% CI= 1.10%, 1.47%, respectively) 
compared to men and women who reported good health (0.41%, 95% CI= 0.35%, 0.48% 
and 0.33%, 95% CI= 0.29%, 0.37%, respectively). Furthermore, both men and women 
who reported having a regular doctor reported a higher percentage of T2D related 
hospitalizations (0.63%, 95% CI= 0.56%, 0.71% and 0.46%, 95% CI= 0.41%, 0.50%, 
respectively) compared to men and women who did not have a regular medical doctor 
(0.17%, 95% CI= 0.12%, 0.23% and 0.21%, 95% CI= 0.13%, 0.30%, respectively). 
Additionally, both men and women who reported visiting a doctor in the past 12 months 
reported a higher percentage of T2D related hospitalizations (0.63%, 95% CI= 0.59%, 
0.77% and 0.45%, 95% CI= 0.40%, 0.49%, respectively) compared to men and women 
who did not visit a doctor in past 12 months (0.23%, 95% CI= 0.17%, 0.30% and 0.37%, 
95% CI= 0.27%, 0.47%, respectively). Both male and female current non-drinkers 
reported higher T2D related hospitalizations (0.95%, 95% CI= 0.76%, 1.14% and 0.84%, 
95% CI= 0.71%, 0.97%, respectively) compared to current drinkers (0.49%, 95% CI= 
0.43%, 0.56% and 0.31%, 95% CI= 0.28%, 0.35%, respectively). Lastly, men who are 
currently non-smokers reported a higher percentage of hospitalizations compared to 
current smokers (0.62%, 95% CI= 0.53%, 0.70% and 0.39%, 95% CI= 0.32%, 0.47%, 
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respectively). For women, the percentage of T2D related hospitalization reported for 
current smokers and non-smokers was the approximately the same (0.44%, 95% CI= 
0.35%, 0.52% and 0.43%, 95% CI= 0.39%, 0.48%, respectively). 
With respect to continuous predictors, the mean age for individuals with a T2D related 
hospitalization was 63.24 (SD=11.54) for men and 64.23 (SD=12.79) for women. This 
was higher than the average age of non-hospitalized respondents: 43.70 (SD=16.39) and 
45.52 (SD=17.25) for men and women, respectively. The hospitalized group had a lower 
mean income category (7.2 [SD=1.96] for men, 6.14 [SD=1.98] for women) compared to 
non-hospitalized respondents (8.18 [SD=2.17] for men, 7.66 [SD=2.36] for women). 
Mean household size for non-hospitalized respondents was slightly higher (2.98 
[SD=1.35] for men, 2.89 [SD=1.36] for women) compared to the hospitalized group 
(2.27 [SD=0.90] for men, and 2.1 [SD=0.90] for women). Both men and women had a 
higher mean BMI in the hospitalized group (28.86 [SD=4.41] and  28.77 [SD=5.91], 
respectively) compared to the non-hospitalized respondents (26.36 [SD=2.49] and 25.07 
[SD=5.18], respectively). For men, the mean MET was 1.65 (SD=1.67) in the 
hospitalized group, whereas it was 2.31 (SD=2.44) in the non-hospitalized respondents. 
For women, the mean MET was 1.16 (SD=1.21) in the hospitalized group while it was 
1.95 (SD=2.04) in the non-hospitalized respondents. Lastly, men in the hospitalized 
group reported slightly higher mean fruit and vegetable consumption (4.66 [SD=2.04]) 
compared to the non-hospitalized respondents (4.43 [SD=2.49]). In contrast, women in 
the hospitalized group reported slightly lower mean fruit and vegetable consumption 
(4.93 [SD=2.10]) compared to non-hospitalized respondents (5.11 [SD=2.57]).  
Table 4.6: Cross tabulation of sociodemographic, health-related, and behavioural 
predictors and type 2 diabetes related hospitalization among adults with unreported 
type 2 diabetes 
 Male ( n = 150,305) Female ( n = 183,415) 
Variables 
T2D related hospitalization (n = 
840) 








Mode of Interview       
Telephone 0.48 0.43 0.54 0.42 0.37 0.47 
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In person 0.68 0.53 0.82 0.46 0.39 0.53 
Age 63.24 (11.54) 61.84 64.63 64.23 (12.79) 62.66 65.80 
Visible minority       
White 0.59 0.53 0.66 0.46 0.41 0.51 
Non-white 0.41 0.20 0.62 0.32 0.22 0.42 
Marital status       
Not married 0.42 0.36 0.49 0.53 0.46 0.60 
Married 0.63 0.54 0.72 0.38 0.33 0.43 
Education       
Less than secondary 
school 
1.13 0.97 1.29 1.09 0.93 1.24 
Secondary school or 
more 
0.46 0.39 0.53 0.32 0.28 0.36 
Income 7.20 (1.96) 6.99 7.42 6.14 (1.98) 5.93 6.35 
Household size 2.27 (0.90) 2.14 2.41 2.1 (0.90) 1.97 2.22 
Rurality       
Urban 0.53 0.46 0.61 0.41 0.37 0.46 
Rural  0.67 0.55 0.79 0.55 0.45 0.64 
BMI 28.86 (4.41) 28.33 29.40 28.77 (5.91) 28.07 29.47 
Self-reported health       
Poor 1.95 1.67 2.24 1.28 1.10 1.47 
Good 0.41 0.35 0.48 0.33 0.29 0.37 
Having a regular 
doctor 
      
No 0.17 0.12 0.23 0.21 0.13 0.30 
Yes 0.63 0.56 0.71 0.46 0.41 0.50 
Visit doctor in past 
12 months 
      
No 0.23 0.17 0.30 0.37 0.27 0.47 
Yes 0.68 0.59 0.77 0.45 0.40 0.49 
Alcohol Drinking       
Currently non-drinker 0.95 0.76 1.14 0.84 0.71 0.97 
Currently drinker 0.49 0.43 0.56 0.31 0.28 0.35 
Smoking tobacco       
Currently non-smoker 0.62 0.53 0.70 0.43 0.39 0.48 
Currently smoker 0.39 0.32 0.47 0.44 0.35 0.52 
Physical Activity 1.65 (1.67) 1.26 2.04 1.16 (1.21) 1.03 1.29 
Fruit and vegetable 
consumption 
4.66 (2.04) 4.27 5.06 4.93 (2.10) 4.71 5.15 
Note: Proportion and confidence interval are presented for categorical variables: mode of interview, visible 
minority, marital status, education, rurality, self-reported health, having a regular doctor, visiting doctor in 
past 12 months, alcohol drinking and smoking tobacco. Mean and standard deviation (SD) with 
corresponding confidence intervals are presented for continuous variables: age, income, household size, 
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BMI, physical activity, and fruits and vegetable consumption. Income and household size frequencies 
distribution table were restricted outside RDC use due to low cell count in some categories.  
Examination of the results from the multivariate logistic regression revealed year of 
interview, age, age^2, BMI, self-reported health, and having a regular doctor were 
statistically significant predictors of T2D related hospitalizations among men with 
unreported T2D. Similarly, age, BMI and self-reported health were statistically 
significant predictors of T2D related hospitalization among women with unreported T2D. 
In contrast, for women, year of interview, age^2 and having a regular doctor were not 
significant predictors of T2D related hospitalization, however, alcohol drinking, smoking 
tobacco, and physical activity were significant predictors of T2D related hospitalization . 
For men, year of interview remained significant after controlling for other covariates 
(OR=1.07, 95% CI=1.03, 1.11). Examination of age revealed that in men, T2D related 
hospitalization increased until 55 years of age, after which, T2D related hospitalizations 
declined. Men also experienced higher odds of T2D related hospitalization with higher 
BMI (OR=1.07, 95% CI=1.06, 1.09). Men who reported poor health had higher odds of 
T2D related hospitalizations (OR=2.14, 95% CI=1.77, 2.58). Furthermore, having a 
regular doctor increased the odds of T2D related hospitalization in men (OR=1.56, 95% 
CI=1.07, 2.26).  
For women, an increased odds of T2D hospitalization was observed until age 91, after 
which, T2D related hospitalization declined. The quadratic term however was not 
statistically significant in women. Among women, an increase in BMI was associated 
with higher odds of T2D related hospitalization (OR=1.08, 95% CI=1.07, 1.10). Those 
who reported poor health experienced higher odds of T2D related hospitalizations 
(OR=1.64, 95% CI=1.31, 2.05). Additionally, women who were current drinkers had 
lower odds of T2D related hospitalization (OR=0.67, 95% CI=0.53, 0.84). Those women 
who were current smokers had higher odds of T2D related hospitalizations (OR=1.56, 
95% CI=1.21, 2.00). Lastly, a higher level of physical activity was associated with lower 
odds of hospitalization among women (OR=0.90, 95% CI=0.84, 0.97). 
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Table 4.7: Association between sociodemographic, health-related and behavioural 
predictors and type 2 diabetes related hospitalization among adults with unreported 
type 2 diabetes 















Year of Interview 1.07 1.03 1.11 0.0005* 1.03 1.00 1.07 0.059 
Mode of 
Interview 
1.14 0.88 1.49 0.3138 0.88 0.72 1.07 0.1945 
Age 4.08 2.85 5.85 <.0001* 2.28 1.54 3.38 <.0001* 
Age^2 0.91 0.87 0.94 <.0001* 0.96 0.92 1.00 0.0776 
Visible minority 1.22 0.72 2.06 0.4640 1.25 0.88 1.79 0.2183 
Marital status 0.93 0.71 1.21 0.5722 1.06 0.78 1.44 0.7183 
Education 0.92 0.74 1.15 0.4797 0.88 0.71 1.09 0.2465 
Income 0.96 0.91 1.01 0.1025 0.94 0.89 1.00 0.0548 
Household size 0.91 0.78 1.06 0.2256 0.91 0.77 1.07 0.2457 
Rurality 1.01 0.8 1.28 0.9466 1.15 0.93 1.42 0.2032 
BMI 1.07 1.06 1.09 <.0001* 1.08 1.07 1.10 <.0001* 
Self-reported 
health 
2.14 1.77 2.58 <.0001* 1.64 1.31 2.05 <.0001* 
Having a regular 
doctor 
1.56 1.07 2.26 0.0196* 1.42 0.91 2.22 0.126 
Visit doctor in 
past 12 months 
1.40 0.98 1.99 0.0642 0.88 0.65 1.19 0.4042 
Alcohol drinking 0.83 0.65 1.05 0.1173 0.67 0.53 0.84 0.0006* 
Smoking tobacco 1.02 0.80 1.3 0.875 1.56 1.21 2.00 0.0006* 




1.03 0.98 1.08 0.2699 0.99 0.95 1.04 0.7183 




5 Discussion  
This chapter will summarize the results of each objective of this study and attempt to 
explain the findings. This chapter further lists the study strengths and limitations. Lastly, 
this chapter will discuss the potential future directions and implications of this research 
followed by a brief conclusion.  
5.1 Key Findings  
Between 2000 to 2009 among Canadian adults with unreported T2D, a higher percentage 
of males compared to females experienced a T2D related hospitalization. In those with 
unreported T2D, the percentage of T2D related hospitalization in men increased linearly 
from 2000 to 2009. The percentage of T2D-related hospitalizations among women with 
unreported T2D did not change from 2000 to 2009. 
The results from the adjusted multivariate logistic regression revealed that year of 
interview, age, BMI, self-reported poor health and having a regular doctor were 
statistically significant predictors of T2D related hospitalizations in men who reported no 
previous T2D diagnosis. Similarly, increasing age, higher BMI and self-reported poor 
health also were significant predictors of T2D related hospitalization in women who 
reported no previous T2D diagnosis. Furthermore, alcohol drinking, smoking tobacco, 
and physical activity were also predictors of T2D related hospitalization in women who 
reported no previous T2D diagnosis. 
5.2 Percentage of type 2 diabetes related hospitalization 
The percentage of men with unreported T2D who experienced a T2D related 
hospitalization was higher than women between 2000 to 2009 (0.56% vs. 0.44%, 
respectively). Past literature has shown that T2D rates are higher among men compared 
to women, with men having 16% higher rates.[33] Men are also at risk for developing 
T2D at a lower BMI compared to women, which may explain why T2D is more common 
among men.[173] This may be because men are more likely to deposit fat in the 
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abdominal region, whereas women are more likely to deposit fat subcutaneously and on 
their lower extremities.[174] Adipose tissue in the abdominal region has been associated 
with increased health risks, including T2D.[174]  
The percentage of T2D related hospitalizations also increased linearly with time for men 
but there was a not significant upward trend observed for women. There is research to 
suggest that BMI has increased globally since 1980.[175] In Canada, 68% of men and 
54% of women were estimated to be overweight or obese.[176] Additionally, between 
1985 and 2011, the prevalence of obesity increased from 6.1% to 18.3%. Increases in 
BMI might lead to an increase in newly diagnosed cases of T2D,[177] as obesity is a 
significant risk factor for T2D development. Adults with a BMI of 40 or higher are 7.37 
times more likely to be diagnosed with T2D.[50] The increase in BMI may explain the 
increase in T2D hospitalization among unreported T2D individuals from 2000 to 2009.  
5.3 Predictors of type 2 diabetes related hospitalization 
5.3.1 Sociodemographic predictors 
The findings from the current study show that CCHS respondents who reported no 
previous T2D diagnoses and experienced T2D related hospitalization were, on average, 
older than those who were not hospitalized. The adjusted multivariate logistic model 
showed that among men, T2D related hospitalization increased until 55 years of age and 
then decreased after that. Previous literature has shown that T2D related hospitalization 
varies by age. A CIHI report indicated a rise in T2D preventable hospitalization event 
until 40-59 years of age followed by a decreased observed from 60-74 years of age.[33] 
In contrast, another study involving First Nations adults concluded that total 
hospitalization among T2D patients decreases until 60 years of age and then increases 
after that.[122] The reason for this pattern may be that those at risk of developing T2D do 
so by 40-59 years of age. After that, the development of T2D might decline, as those who 
are at risk or predisposed to developing T2D might have developed it already.[173,178] 
The adjusted multivariate logistic model showed that among women, T2D related 
hospitalization increased until 91 years of age and then decreased after that; however, the 
quadratic term was not significant. According to a systematic review, more women are 
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overweight or obese after the age of 45 years, whereas more males are overweight at a 
younger age.[178] Women might develop T2D at an older age, which may explain why 
T2D hospitalizations do not show a significant decline in women with increasing age. 
Lastly, previous literature suggests that men are diagnosed with T2D at a lower BMI 
than women.[173] Therefore, T2D hospitalization events might be occur at a younger 
age in men and decline after that.  
The results of this study showed that individuals in the white ethnic group reported a 
higher percentage of T2D hospitalization. This was true for both men and women. 
Furthermore, men who reported being married reported higher T2D related 
hospitalization, while women who reported being married reported lower T2D related 
hospitalization. In the adjusted multivariate logistic model, neither visible minority nor 
marital status were statistically significant predictors of T2D related hospitalization. 
Previous literature observed similar results; those who were married were less likely to 
have a T2D related hospitalization event, but this was not significant after controlling for 
confounders.[118] A Canadian study found that First Nations adults had almost four 
times the odds of having a hospitalization or emergency department visit for a T2D 
related events.[122] The rate of preventable hospitalizations among urban Métis adults 
was found to be twice that of non-Indigenous adults.[126] However, the visible minority 
variable used in this study was a binary variable (white/non-white) where the non-white 
comprise of a mix of all ethnic groups. Not all ethnic groups share the same risk of T2D 
and hospitalization risk. The effect of certain ethnic groups on hospitalization risk might 
have diminished the effects of others. For example, immigrants from the Caribbean, 
Europe and East Asia have been found to have lower odds of preventable hospitalization 
and the effect may be transgenerational.[179] 
Among men and women, a higher percentage of T2D related hospitalization were 
reported among individuals with less than secondary schooling. Additionally, a lower 
average mean income was reported for the T2D related hospitalization group. In the 
adjusted multivariate logistic model, neither income nor education were statistically 
significant for men or women; household size was controlled to standardize the 
household income per individuals. These finding are in contrast to other studies. Findings 
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from one study suggests that the effect of education is not significant after controlling for 
income, which usually is a significant predictor of T2D related hospitalization.[118] 
Another study, by Chen et al., found socioeconomic effects of higher education as well as 
individual income were important factors which affect disparities in T2D related 
hospitalization.[119] However, in the study by Chen et al., education was recorded at the 
community level and they did not look at behavioural predictors.[119] Booth and Hux 
found an inverse gradient between income level and T2D hospitalizations.[120] 
However, Booth and Hux did not control for behavioural factors, and more importantly, 
individual income was estimated from neighborhood income which may lead to 
misclassification.[120] In the current study, there was not a significant effect of income 
on T2D related hospitalization. This may suggest that universal care may be succeeding 
in removing disparities associated with education and income. Additionally, income 
might not be reliably reported in the CCHS dataset. For instance, income variable was 
imputed due to 8.77% and 12.32% of the values missing for men and women.  
Lastly, respondents who lived in rural areas were more likely to report hospitalization for 
T2D, however in the adjusted multivariate logistic model, this variable was not 
significant for males or females. In contrast, other studies have shown hospitalization 
rates were 60% higher in rural areas compared to urban areas.[33] An Ontario study 
found that more remote northern areas had higher rates of admission for hypoglycemia 
and emergency department visits for T2D between 1994 through 1999; but these areas 
experienced comparable or even greater declines in admission for hypoglycemia and 
emergency department visits for T2D compared to areas in southern Ontario.[44] This 
could indicate that efforts to mitigate the effects of accessibility in rural areas has been 
successful. Furthermore, residence of rural areas are more likely to be obese or 
overweight compared to urban dwellers.[180] After adjusting for BMI, the effects of 
rurality might diminish.  
5.3.2 Health-related predictors 
On average, men and women hospitalized for T2D had higher BMI. Both men and 
women who self-reported poor health also reported higher T2D related hospitalizations. 
In the adjusted multivariate logistic model, both BMI and self-reported poor health were 
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significant predictors of T2D related hospitalization for both men and women. Similar to 
previous studies, adults with overweight and obesity tend to have increased incidence of 
both general hospitalization and preventable hospitalization.[118,124] Furthermore, T2D 
can be accompanied by several other health conditions and worse health status is a 
predictor of hospitalization.[123] Previous studies have shown that having comorbidities 
with T2D increases the odds of hospitalization; with one comorbidity having higher odds 
of hospitalization compared to no comorbidity, and two or more comorbidities having 
even higher odds of hospitalization.[119] Obesity in people with T2D is associated with 
poor control of blood sugar, blood pressure and cholesterol levels; many of the health 
complications of T2D become more severe when they are compounded by overweight or 
obesity.[50–52] These contributing factors indicate why increased hospitalizations 
occurred among respondents with higher BMI. 
5.3.3 Behavioural predictors 
The results showed that individuals who reported having a regular doctor and visiting a 
doctor in the past 12 months also reported a higher percentage of T2D related 
hospitalization among men and women. The adjusted multivariate logistic model 
revealed that visiting a doctor in the past 12 months was not a significant predictor of 
hospitalization in either men or women. However, having a regular doctor was 
significantly associated with increased odds of hospitalization, but only for men. The 
potential reasons for observing these results may be that a higher percentage of men who 
have worse health seek to or are encouraged to have a regular doctor. Whereas women, 
who are generally more health conscious,[181,182] might see their regular doctor before 
their health worsens.  
Previous literature reveals an equal percentage of hospitalization among those who 
consulted a doctor in past 12 months and those who did not.[123] A different study 
showed that, at an aggregated level, the average annual number of doctor visits per 
person had a U-shaped association with hospitalizations for all conditions combined. 
Specifically for patients with T2D, ischemic heart disease or renal disease, the lowest 
number of hospitalizations were found when there was 20 to 30 doctor visits a year.[183] 
A study from Alberta, Canada found that limited or increased use of primary care among 
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T2D patients was associated with increased risk of a subsequent hospitalization.[128] 
Those who visited primary care too much or too little were more likely to be 
hospitalized.[128] Higher use of primary care services may indicate worse health. Also, 
not using primary care services can lead to worsening of T2D related complications.[128] 
These studies suggest that the relationship between the number of consultations with 
doctor and hospitalizations might not be a linear relationship. In this study, the variable 
indicating the number of visits to a doctor was a binary variable and a linear relationship 
was not tested.  
Among men, current non-drinkers and current non-smokers reported a higher percentage 
of T2D hospitalizations. Among women, current drinkers and non-drinkers reported a 
similar percentage of T2D related hospitalizations. In the adjusted multivariate logistic 
model, smoking tobacco and alcohol drinking status was not a significant predictor of 
T2D related hospitalization among men. In contrast, smoking tobacco and alcohol 
drinking were significant predictors of T2D hospitalization among women. These results 
align with previous Canadian literature which suggests that smoking is a risk factor for 
hospitalization, whereas occasional/moderate alcohol drinking is a protective factor 
against hospitalization.[123] Conflicting results come from some studies that aggregated 
the results for men and women; for example, smoking status and alcohol consumption 
were not related to T2D hospitalization.[118,184] However, this study examined these 
predictors separately for men and women and it was found that alcohol drinking, smoking 
tobacco and physical activity are significant predictors in women alone. Moderate alcohol 
consumption has been shown to lower the risk of T2D. A systematic review found that 
alcohol intake below 63 g/day played a protective role against T2D, with risk increasing 
above that threshold.[66] However, reductions in risk appeared to be specific to women, 
who exhibit a decreased risk of T2D.[66] A possible explanation for the sex differences 
could be that men more frequently drink heavily compared to women.[185] Another 
systematic review and meta-analysis showed moderate alcohol consumption might 
improve insulin sensitivity among women.[186] Both former and current smoking has 
been independently associated with a higher risk of incident T2D in men and 
women.[187] Also, the smoking variable used in this study was a binary variable 
indicating current smoking status. The reference group, current non-smokers, might have 
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been contaminated with less healthy former smokers. This contamination might be higher 
for men than women.  
Lastly, results of this study show that men and women hospitalized for T2D had, on 
average, a lower volume of physical activity measured in MET and less fruit and 
vegetable consumption. In the adjusted multivariate logistic model, fruit and vegetable 
consumption was not a significant predictor of T2D hospitalization for men or women. 
Additionally, physical activity was not a significant predictor of T2D hospitalization for 
men, however, it was a significant predictor for women. Previous literature has shown 
that increased levels of physical activity can reduce preventable hospitalization in both 
men and women.[118] There is strong evidence for an inverse association between 
physical activity and risk of T2D, which may partly be mediated by reduced 
adiposity.[71] Modifiable behaviours, which are correlated with one another, might also 
have a greater influence on women. Other health behaviours such as increasing the 
amount of green leafy vegetables in an individual’s diet has been shown to help reduce 
the risk of T2D.[67,68] Habitual consumption of sugar sweetened beverages has been 
shown to be associated with a greater incidence of T2D, independently of adiposity.[69] 
Furthermore, meat consumption has shown to increase risk of T2D.[70] However, the 
current study only measured fruit and vegetable consumption and did not control for 
other food groups which might mitigate the effects of increased fruit and vegetable 
consumption.   
5.4 Strengths and Limitations 
This study has both strengths and limitations. To our knowledge, this is the first Canadian 
study to examine T2D related hospitalizations among patients with unreported T2D. 
Also, this is the first Canadian study to look at temporal trends in T2D related 
hospitalization among patients with unreported T2D. A major strength of this study is 
that hospitalization data was used from hospitals across Canada, except Quebec. This 
comprehensive data source represented ~75% of all hospital separations in Canada and 
maintained standards for quality and consistency.[136] Additionally, the CCHS provides 
a rich source of information on self-reported health status and determinants of health, but 
lacks the details needed to study hospitalization events.[136] Linking the DAD with the 
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CCHS helped generate a better understanding about what brings Canadians in contact 
with acute care facilitates.[136] As a result of the large sample size, this study was able to 
analyze a number of sociodemographic, health-related and behavioural predictors of T2D 
related hospitalization.  
One of the more significant limitations of this study was the self-reported T2D indicator 
from the CCHS. In order for a person to self-report having diabetes, they must recognize 
the term diabetes, have some knowledge of the disease, and associate the term with 
themselves.[188] However, not all CCHS respondents who may have been diagnosed 
with T2D will self-report that they have the disease. Respondents may not self-report 
having T2D for the following reasons: they do not understand the term; they might have 
never have been informed about the diagnosis; they have been informed of the diagnosis 
but they may disagree with the diagnosis; they may believe, since they are managing their 
condition, that the disease is cured; they may be aware and informed of T2D but are 
hiding the diagnosis because of stigma.[188] A Canadian study in Ontario examined the 
proportion of individuals with physician diagnosed T2D who reported having diabetes in 
population health survey in 2001. They found that only 75% of people with physician 
diagnosed T2D reported having the disease.[188] Additionally, respondents who did not 
self-report their T2D status were more likely to be women, live in urban areas, and have a 
shorter T2D disease duration.[188] Respondents who did not report their T2D status were 
less likely to require hospital care for hyperglycaemia.[188]  
Self-reported data might also have been subject to social desirability bias or recall bias. 
For example, CCHS respondents might answer questions regarding health behaviours 
more positively because they believe it to be more socially acceptable.[189] Additionally, 
respondents might not remember accurately the answer to variables, such as fruit and 
vegetable consumption.  
This study employed a three-year follow-up period. We anticipated that if a CCHS 
respondent reported no diagnosis of T2D at the time of their CCHS interview and was 
hospitalized within three years for a T2D related condition, it is likely they had 
undiagnosed T2D when the CCHS interview was conducted. However, individual may 
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have seen a doctor or taken lab tests diagnosing them with diabetes during this follow-up 
period. In which case, they would not be considered undiagnosed at the time of 
hospitalization. 
Non-response to the CCHS might have biased the results of this study, as well. The 
CCHS response rate ranged from 69.8% to 78.9%.[137] The characteristics of those who 
agreed to participate in the CCHS might be different than those who did not agree to 
participate. Furthermore, 84.7% of those who completed the CCHS interview further 
agreed to share their data for linkage.[151] The CCHS might also underestimate T2D 
related hospitalizations due to selection bias. For instance, excluded from the CCHS are: 
persons living on reserves and other Aboriginal settlements, full-time members of the 
Canadian Forces, and institutionalized population.[137] The excluded population might 
possess different characteristics compared to the included population. For example, 
people living on reserves might have a higher T2D related hospitalizations.  
Another limitation of this study is that this thesis did not utilized laboratory data or 
physician billing to confirm T2D diagnosis and investigate clinical predictors of T2D 
related hospitalizations. Furthermore, a qualitative study found that variables such as 
extreme social vulnerability (such as homeless, poverty and no social support), health 
system interaction issues (such as poor communication with providers), limited health-
related knowledge, behavioural health issues (such as substance abuse and mental 
illness), denial of illness and practical problems (such as being too busy) were some of 
the reasons listed for T2D related hospitalizations.[190] This study did not control for 
these factors, which might lead to residual confounding. Other important factors such as 
comorbidity was also not controlled for; which has also been linked to elevating diabetes 
hospitalizations.[191]   
The DAD might also underestimate T2D related diagnosis. A Spanish study examined a 
cohort of 1036 patients admitted to a hospital over a seven-day period. They found 178 
patients had T2D; 15% of admitted patients had previously diagnosed and 1.9% had been 
newly diagnosed. Out of the 178 T2D cases, 144 were recorded in the discharge record, 
that is 19% of T2D cases were not reported in administrative datasets.[192] Other studies 
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have also shown under-reporting of T2D cases in a hospital setting.[31,193,194] 
Therefore, the true incidence of T2D hospitalization among self-reported undiagnosed 
diabetes might be underestimated.  
The variable utilized to represent the construct of income had limitations as well. First, 
the income variable was not standardized to geographic differences in cost of living. 
Secondly, the income categories representing low-high income on a scale of 0-10 
remained constant over the CCHS cohorts used in this study. This is problematic as low-
high income cutoffs change over place and time. Although the CCHS over the years has 
developed income variables that are standardized to account for variability over place and 
time, these variables were not available in the early years of the survey and were not 
available for the Canadian territories.   
Lastly, poor measurement of constructs such as alcohol drinking, fruits and vegetable 
consumption, BMI can create bias which can distort study results. For example, CCHS 
participants were asked to recall if they drank in the past year, however, this did not 
include how much alcohol was consumed. Excessive drinking might pose a larger 
problem than drinking frequency.[195] Another poor measurement of construct might 
have been fruits and vegetable consumption. CCHS respondents were asked to recall the 
frequency of fruits and vegetable consumption. However, this may be subject to recall 
bias. Furthermore, measurement of other unhealthy food choices was not assessed. 
Lastly, studies have shown that measurements such as waist circumference and waist to 
hit ratio are slightly better at predicting diabetes and diabetes complications in both sexes 
compared to BMI.[196,197] 
5.5 Implications and further direction 
In direct response to the potential limitations of the present study, it is of interest to 
utilize more reliable methods of ascertaining undiagnosed T2D and T2D related 
hospitalizations. Ensuring health administrative dataset are capturing diagnosis accurately 
and using clinical data, such as laboratory tests, to ascertain outcome. 
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The results of this thesis align with previous literature suggesting T2D prevalence tends 
to be higher in men,[33] and men also develop T2D at a lower BMI compared to 
women.[173] Similarly, undiagnosed T2D is higher in men compared to women.[79,80] 
Practical implications of this finding can include health care providers being aware of the 
higher risk of T2D incidence among men. Higher incidence of T2D in men can lead to 
higher rates of T2D cases going undiagnosed. Therefore, theoretically, screening in men 
should occur at a lower BMI compared to women. Previous literature has examined why 
men experience higher rates of T2D compared to women and suggests that adipose tissue 
is associated with increased risk of T2D and men are more likely to deposit fat in the 
abdominal region compared to women.[174] However, there is no consensus on why men 
experience higher rates of T2D compared to women. Future research should focus on the 
causal pathway of T2D and how this differs between genders, including non-binary 
groups.  
Percentage of T2D related hospitalization among unreported T2D patients increased from 
the period 2000-2009. Research suggests an increase in overweight and obesity in 
Canada, more so in men than in women.[176] Increases in BMI might lead to an increase 
in newly diagnosed cases of T2D.[177] This should raise the alarm for policy makers and 
health care providers as with increasing economic costs, diagnosing T2D at an early stage 
is key to affording the opportunity to treat T2D, and T2D control is key to reducing the 
risk of complications. Future research should assess reasons for the rise in T2D related 
hospitalization among undiagnosed T2D Canadians, given that crude T2D related are 
decreasing. 
In the US, there is evidence to suggest that undiagnosed T2D crude prevalence increased 
during the past two decades but has decreased over time as a proportion of total T2D 
cases.[90] Although there is literature in Canada that aims to estimate the prevalence of 
undiagnosed T2D, there is a lack of literature on temporal trends in crude undiagnosed 
T2D prevalence in the Canadian context. Due to the lack of Canadian literature on 
national trends in crude undiagnosed T2D prevalence, the rise in T2D related 
hospitalization among undiagnosed T2D Canadian cannot directly be compared. Future 
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research should concentrate on examining national trends in crude undiagnosed T2D 
prevalence.  
The results from the adjusted multivariate logistic regression revealed that age, BMI, self-
reported health and having a regular doctor were statistically significant predictors of 
T2D related hospitalizations in Canadian adults. Whereas, visible minority, income and 
rurality were not significant predictors of T2D related hospitalization. These findings are 
in contrast to other studies on ethnicity,[122,126,179] income,[118–120] and rurality.[33] 
Modifiable health behaviours such as drinking alcohol, smoking tobacco and physical 
activity were associated with T2D related hospitalization among women. The practical 
implications of these finding are that modifiable health behaviours can aid in creating a 
healthier society and these modifiable health behaviours might be more important in 
women’s health. This thesis could not explain why males and females differed in their 
predictors for T2D related hospitalization. Future research should aim to explore the sex 
differences observed in T2D related hospitalization for modifiable health behaviours.  
While much research focuses on predictors of T2D related hospitalization among people 
with T2D in Canada, more research needs to focus on understanding the determinants of 
T2D related hospitalization among people with undiagnosed T2D and how they are 
associated with experiencing undiagnosed T2D and subsequent preventable 
hospitalization. This thesis was not able to examine clinical predictors, such FPG levels, 
which have been previously associated with increased T2D hospitalization risk.[114] 
With plans for linkage projects involving the CCHS and the CIHI datasets in the future, 
research should examine clinical predictors, as well as controlling for a plethora of other 
confounders of T2D related hospitalization.  
5.6 Conclusion 
Between 2000 and 2009, a higher percentage of males compared to females with 
unreported T2D experienced a T2D related hospitalization event. Identifying undiagnosed 
diabetes could be an effective strategy to minimize the long‐term impacts of the disease. 
Screening intervention could permit timely initiation of therapy designed to prevent or 
delay the occurrence of complications. Additionally, this thesis examined the temporal 
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trends in T2D related hospitalization among individuals with unreported T2D. The 
percentage of T2D related hospitalizations among men with unreported T2D increased 
linearly from 2000 to 2009. With the rise in T2D related hospitalizations among 
individuals with unreported T2D, potentially due to increased prevalence of obesity and 
newly, policymakers should address this issue. 
Lastly, this thesis explored potential sociodemographic, health-related and behavioural 
predictors of T2D related hospitalization among individuals with undiagnosed T2D. The 
adjusted multivariate logistic regression revealed that age, BMI, self-reported health were 
significant predictors of T2D related hospitalizations in men and women. However, 
alcohol drinking, smoking tobacco, and physical activity were significant predictors of 
T2D related hospitalization in women only. Modifiable health behaviours might have a 
greater influence on women. While the current analysis was not able to ascertain 
causality, future research should focus on understanding these relationships. Future 
research should also focus on linking other administrative datasets, such as physician 
billing or laboratory results, to ascertain T2D diagnosis status. Furthermore, identifying 





1  World Health Organization. Diabetes. https://www.who.int/news-room/fact-
sheets/detail/diabetes (accessed 26 Dec 2018). 
2  Public Health Agency of Canada. Diabetes in Canada: facts and figures from a 
public health perspective. Ottawa Ont: : Public Health Agency of Canada 2011.  
3  Roglic G, World Health Organization, editors. Global report on diabetes. Geneva, 
Switzerland: : World Health Organization 2016.  
4  Public Health Agency of Canada. Diabetes in Canada. Gov. Can. 2017. 
https://www.canada.ca/en/public-health/services/publications/diseases-
conditions/diabetes-canada-highlights-chronic-disease-surveillance-system.html 
(accessed 31 Dec 2018). 
5  Canadian Diabetes Association. Diabetes Statistics in Canada. Can. Diabetes Assoc. 
http://www.diabetes.ca/how-you-can-help/advocate/why-federal-leadership-is-
essential/diabetes-statistics-in-canada (accessed 31 Dec 2018). 
6  Gregg EW. The Changing Tides of the Type 2 Diabetes Epidemic—Smooth Sailing 
or Troubled Waters Ahead? Kelly West Award Lecture 2016. Diabetes Care 
2017;40:1289–97. doi:10.2337/dci16-0055 
7  World Health Organization. About Diabetes: Complications of Diabetes. WHO. 
https://www.who.int/diabetes/action_online/basics/en/index3.html (accessed 24 Jul 
2019). 
8  Lee WL, Cheung AM, Cape D, et al. Impact of diabetes on coronary artery disease 
in women and men: a meta-analysis of prospective studies. Diabetes Care 
2000;23:962–8. doi:10.2337/diacare.23.7.962 
9  Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for 
cardiovascular disease: the Framingham study. Diabetes Care 1979;2:120–6. 
doi:10.2337/diacare.2.2.120 
10  Booth GL, Kapral MK, Fung K, et al. Relation between age and cardiovascular 
disease in men and women with diabetes compared with non-diabetic people: a 
population-based retrospective cohort study. 2006;368:8. 
11  Fong DS, Aiello L, Gardner TW, et al. Retinopathy in Diabetes. Diabetes Care 
2004;27:s84–7. doi:10.2337/diacare.27.2007.S84 
12  Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study of 
Diabetic Retinopathy: III. Prevalence and Risk of Diabetic Retinopathy When Age 




13  Gheith O, Farouk N, Nampoory N, et al. Diabetic kidney disease: world wide 
difference of prevalence and risk factors. J Nephropharmacology 2015;5:49–56. 
14  Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various 
types of diabetic neuropathy, retinopathy, and nephropathy in a population-based 
cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43:817–24. 
doi:10.1212/wnl.43.4.817 
15  Jaiswal M, Divers J, Dabelea D, et al. Prevalence of and Risk Factors for Diabetic 
Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for 
Diabetes in Youth Study. Diabetes Care 2017;40:1226–32. doi:10.2337/dc17-0179 
16  Bommer C, Heesemann E, Sagalova V, et al. The global economic burden of 
diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes 
Endocrinol 2017;5:423–30. doi:10.1016/S2213-8587(17)30097-9 
17  Bommer C, Sagalova V, Heesemann E, et al. Global Economic Burden of Diabetes 
in Adults: Projections From 2015 to 2030. Diabetes Care 2018;:dc171962. 
doi:10.2337/dc17-1962 
18  Canadian Diabetes Association. Economic Tsunami: The Cost of Diabetes in 
Canada. Can. Diabetes Assoc. http://www.diabetes.ca/publications-
newsletters/advocacy-reports/economic-tsunami-the-cost-of-diabetes-in-canada 
(accessed 8 Jan 2019). 
19  Rosella LC, Lebenbaum M, Fitzpatrick T, et al. Impact of diabetes on healthcare 
costs in a population-based cohort: a cost analysis. Diabet Med J Br Diabet Assoc 
2016;33:395–403. doi:10.1111/dme.12858 
20  Bilandzic A, Rosella L. The cost of diabetes in Canada over 10 years: applying 
attributable health care costs to a diabetes incidence prediction model. Chronic Dis 
Inj Can Ott 2017;37:n/a. 
21  Harris MI, Klein R, Welborn TA, et al. Onset of NIDDM occurs at Least 4–7 yr 
Before Clinical Diagnosis. Diabetes Care 1992;15:815–9. 
doi:10.2337/diacare.15.7.815 
22  Young TK, Mustard CA. Undiagnosed diabetes: Does it matter? CMAJ 
2001;164:24–8. 
23  Canadian Diabetes Association. Complications. Can. Diabetes Assoc. 
http://www.diabetes.ca/diabetes-and-you/complications (accessed 7 Jan 2019). 
24  Ekoe J-M, Goldenberg R, Katz P. Screening for Diabetes in Adults. Can J Diabetes 
2018;42:S16–9. doi:10.1016/j.jcjd.2017.10.004 
25  National Diabetes Surveillance System (NDSS) Steering Committee (Canada), 
Health Canada. Responding to the challenge of diabetes in Canada: first report of 
78 
 
the National Diabetes Surveillance System(NDSS) 2003. Ottawa, Ont.: : Health 
Canada 2003.  
26  Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: An Independent 
Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes. J Clin 
Endocrinol Metab 2002;87:978–82. doi:10.1210/jcem.87.3.8341 
27  Giraldez RR, Clare RM, Lopes RD, et al. Prevalence and clinical outcomes of 
undiagnosed diabetes mellitus and prediabetes among patients with high-risk non–
ST-segment elevation acute coronary syndrome. Am Heart J 2013;165:918-925.e2. 
doi:10.1016/j.ahj.2013.01.005 
28  Lauruschkat Achim H., Arnrich Bert, Albert Alexander A., et al. Prevalence and 
Risks of Undiagnosed Diabetes Mellitus in Patients Undergoing Coronary Artery 
Bypass Grafting. Circulation 2005;112:2397–402. 
doi:10.1161/CIRCULATIONAHA.105.534545 
29  Roche MM, Wang PP. Sex Differences in All-Cause and Cardiovascular Mortality, 
Hospitalization for Individuals With and Without Diabetes, and Patients With 
Diabetes Diagnosed Early and Late. Diabetes Care 2013;36:2582–90. 
doi:10.2337/dc12-1272 
30  Flores-Le Roux JA, Comin J, Pedro-Botet J, et al. Seven-year mortality in heart 
failure patients with undiagnosed diabetes: an observational study. Cardiovasc 
Diabetol 2011;10:39. doi:10.1186/1475-2840-10-39 
31  Malcolm JC, Kocourek J, Keely E, et al. Implementation of a Screening Program to 
Detect Previously Undiagnosed Dysglycemia in Hospitalized Patients. Can J 
Diabetes 2014;38:79–84. doi:10.1016/j.jcjd.2014.02.005 
32  Billings J, Zeitel L, Lukomnik J, et al. Impact Of Socioeconomic Status On Hospital 
Use In New York City. Health Aff (Millwood) 1993;12:162–73. 
doi:10.1377/hlthaff.12.1.162 
33  Canadian Institute for Health Information. Health indicators 2008. Ottawa: : 
Canadian Institute for Health Information 2008. 
https://secure.cihi.ca/free_products/HealthIndicators2008_ENGweb.pdf 
34  Information (CIHI) CI for H. Primary Health Care in Canada: A Chartbook of 
Selected Indicator Results, 2016. 
https://www.cihi.ca/sites/default/files/methodology_notes_for_phc_chartbook_indic
ators_en_web.pdf (accessed 17 Jun 2019). 
35  Wolters RJ, Braspenning JCC, Wensing M. Impact of primary care on hospital 




36  Dusheiko M, Doran T, Gravelle H, et al. Does Higher Quality of Diabetes 
Management in Family Practice Reduce Unplanned Hospital Admissions? Health 
Serv Res 2011;46:27–46. doi:10.1111/j.1475-6773.2010.01184.x 
37  Kim S. Burden of Hospitalizations Primarily Due to Uncontrolled Diabetes: 
Implications of inadequate primary health care in the United States. Diabetes Care 
2007;30:1281–2. doi:10.2337/dc06-2070 
38  Sanmartin CA, Khan S, Statistics Canada, et al. Hospitalizations for ambulatory 
care sensitive conditions (ACSC): the factors that matter. Ottawa: : Statistics 
Canada, Health Information and Research Division 2011.  
39  Silverman RA, Schleicher MG, Valente CJ, et al. Prevalence of undiagnosed 
dysglycemia in an emergency department observation unit. Diabetes Metab Res Rev 
2016;32:82–6. doi:10.1002/dmrr.2674 
40  Greci LS, Kailasam M, Malkani S, et al. Utility of HbA1c Levels for Diabetes Case 
Finding in Hospitalized Patients With Hyperglycemia. Diabetes Care 
2003;26:1064–8. doi:10.2337/diacare.26.4.1064 
41  Thakker U, Ellman T, Magleby R, et al. The impact of acute illness on HbA1c 
determination of undiagnosed diabetes. Diabetes Metab. Res. Rev. 2012. 
doi:10.1002/dmrr.2315 
42  Müller‐Wieland D, Merkel M, Hamann A, et al. Survey to estimate the prevalence 
of type 2 diabetes mellitus in hospital patients in Germany by systematic HbA1c 
measurement upon admission2. Int J Clin Pract 2018;72:n/a-n/a. 
doi:10.1111/ijcp.13273 
43  Laberge M, Kone Pefoyo AJ. Assessing the Effectiveness of Policies to Reduce 
Diabetes Hospitalizations Before and After the Reforms of Physician Payment and 
Primary Care Organization in British Columbia and Alberta. Can J Diabetes 
2016;40:406–10. doi:10.1016/j.jcjd.2016.02.010 
44  Booth GL, Hux JE, Fang J, et al. Time trends and geographic disparities in acute 
complications of diabetes in Ontario, Canada. Diabetes Care 2005;28:1045–50. 
doi:10.2337/diacare.28.5.1045 
45  Herman WH, Ye W, Griffin SJ, et al. Early Detection and Treatment of Type 2 
Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the 
Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With 
Screen-Detected Diabetes in Primary Care (ADDITION-Europe). Diabetes Care 
2015;38:1449–55. doi:10.2337/dc14-2459 
46  Kahn R, Alperin P, Eddy D, et al. Age at initiation and frequency of screening to 




47  Röder PV, Wu B, Liu Y, et al. Pancreatic regulation of glucose homeostasis. Exp 
Mol Med 2016;48:e219. doi:10.1038/emm.2016.6 
48  Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of 
pathogenesis and therapy. Lancet Lond Engl 2005;365:1333–46. 
doi:10.1016/S0140-6736(05)61032-X 
49  Brannick B, Wynn A, Dagogo-Jack S. Prediabetes as a toxic environment for the 
initiation of microvascular and macrovascular complications. Exp Biol Med 
2016;241:1323–31. doi:10.1177/1535370216654227 
50  Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of Obesity, Diabetes, and 
Obesity-Related Health Risk Factors, 2001. JAMA 2003;289:76–9. 
doi:10.1001/jama.289.1.76 
51  Bellou V, Belbasis L, Tzoulaki I, et al. Risk factors for type 2 diabetes mellitus: An 
exposure-wide umbrella review of meta-analyses. PLOS ONE 2018;13:e0194127. 
doi:10.1371/journal.pone.0194127 
52  Bramante CT, Lee CJ, Gudzune KA. Treatment of Obesity in Patients With 
Diabetes. Diabetes Spectr 2017;30:237–43. doi:10.2337/ds17-0030 
53  Leong A, Rahme E, Dasgupta K. Spousal diabetes as a diabetes risk factor: A 
systematic review and meta-analysis. BMC Med 2014;12:12. doi:10.1186/1741-
7015-12-12 
54  Agardh E, Allebeck P, Hallqvist J, et al. Type 2 diabetes incidence and socio-
economic position: a systematic review and meta-analysis. Int J Epidemiol 
2011;40:804–18. doi:10.1093/ije/dyr029 
55  Walker RJ, Gebregziabher M, Martin-Harris B, et al. Independent effects of 
socioeconomic and psychological social determinants of health on self-care and 
outcomes in Type 2 diabetes. Gen Hosp Psychiatry 2014;36:662–8. 
doi:10.1016/j.genhosppsych.2014.06.011 
56  Walker RJ, Smalls BL, Campbell JA, et al. Impact of social determinants of health 
on outcomes for type 2 diabetes: a systematic review. Endocrine 2014;47:29–48. 
doi:10.1007/s12020-014-0195-0 
57  Menke A, Casagrande S, Geiss L, et al. Prevalence of and Trends in Diabetes 
Among Adults in the United States, 1988-2012. JAMA 2015;314:1021–9. 
doi:10.1001/jama.2015.10029 
58  Ke C, Sohal P, Qian H, et al. Diabetes in the young: a population‐based study of 




59  Oster RT, Johnson JA, Balko SU, et al. Increasing rates of diabetes amongst status 
Aboriginal youth in Alberta, Canada. Int J Circumpolar Health 2012;71. 
doi:10.3402/ijch.v71i0.18501 
60  Turin TC, Saad N, Jun M, et al. Lifetime risk of diabetes among First Nations and 
non–First Nations people. CMAJ 2016;188:1147–53. doi:10.1503/cmaj.150787 
61  Billings LK, Florez JC. The genetics of type 2 diabetes: what have we learned from 
GWAS? Ann N Y Acad Sci 2010;1212:59–77. doi:10.1111/j.1749-
6632.2010.05838.x 
62  Herder C, Roden M. Genetics of type 2 diabetes: pathophysiologic and clinical 
relevance. Eur J Clin Invest 2011;41:679–92. doi:10.1111/j.1365-
2362.2010.02454.x 
63  Ali O. Genetics of type 2 diabetes. World J Diabetes 2013;4:114–23. 
doi:10.4239/wjd.v4.i4.114 
64  Hemminki K, Li X, Sundquist K, et al. Familial Risks for Type 2 Diabetes in 
Sweden. Diabetes Care 2010;33:293–7. doi:10.2337/dc09-0947 
65  Willi C, Bodenmann P, Ghali WA, et al. Active smoking and the risk of type 2 
diabetes: a systematic review and meta-analysis. JAMA 2007;298:2654–64. 
doi:10.1001/jama.298.22.2654 
66  Knott C, Bell S, Britton A. Alcohol Consumption and the Risk of Type 2 Diabetes: 
A Systematic Review and Dose-Response Meta-analysis of More Than 1.9 Million 
Individuals From 38 Observational Studies. Diabetes Care 2015;38:1804–12. 
doi:10.2337/dc15-0710 
67  Schwingshackl L, Hoffmann G, Lampousi A-M, et al. Food groups and risk of type 
2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. 
Eur J Epidemiol 2017;32:363–75. doi:10.1007/s10654-017-0246-y 
68  Wang P-Y, Fang J-C, Gao Z-H, et al. Higher intake of fruits, vegetables or their 
fiber reduces the risk of type 2 diabetes: A meta-analysis. J Diabetes Investig 
2016;7:56–69. doi:10.1111/jdi.12376 
69  Imamura F, O’Connor L, Ye Z, et al. Consumption of sugar sweetened beverages, 
artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: 
systematic review, meta-analysis, and estimation of population attributable fraction. 
Br J Sports Med 2016;50:496–504. doi:10.1136/bjsports-2016-h3576rep 
70  Aune D, Ursin G, Veierød MB. Meat consumption and the risk of type 2 diabetes: a 




71  Aune D, Norat T, Leitzmann M, et al. Physical activity and the risk of type 2 
diabetes: a systematic review and dose–response meta-analysis. Eur J Epidemiol 
2015;30:529–42. doi:10.1007/s10654-015-0056-z 
72  Ellis JD, Zvandasara T, Leese G, et al. Clues to duration of undiagnosed disease 
from retinopathy and maculopathy at diagnosis in type 2 diabetes: a cross-sectional 
study. Br J Ophthalmol 2011;95:1229–33. doi:10.1136/bjo.2010.196204 
73  Porta M, Curletto G, Cipullo D, et al. Estimating the Delay Between Onset and 
Diagnosis of Type 2 Diabetes From the Time Course of Retinopathy Prevalence. 
Diabetes Care 2014;37:1668–74. doi:10.2337/dc13-2101 
74  Punthakee Z, Goldenberg R, Katz P. Definition, Classification and Diagnosis of 
Diabetes, Prediabetes and Metabolic Syndrome. Can J Diabetes 2018;42:S10–5. 
doi:10.1016/j.jcjd.2017.10.003 
75  Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus 
and its complications. Part 1: diagnosis and classification of diabetes mellitus 
provisional report of a WHO consultation. Diabet Med J Br Diabet Assoc 
1998;15:539–53. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-
DIA668>3.0.CO;2-S 
76  Beagley J, Guariguata L, Weil C, et al. Global estimates of undiagnosed diabetes in 
adults. Diabetes Res Clin Pract 2014;103:150–60. 
doi:10.1016/j.diabres.2013.11.001 
77  Leahy S, O’ Halloran AM, O’ Leary N, et al. Prevalence and correlates of 
diagnosed and undiagnosed type 2 diabetes mellitus and pre-diabetes in older adults: 
Findings from the Irish Longitudinal Study on Ageing (TILDA). Diabetes Res Clin 
Pract 2015;110:241–9. doi:10.1016/j.diabres.2015.10.015 
78  Islam FMA, Chakrabarti R, Islam MT, et al. Prediabetes, diagnosed and 
undiagnosed diabetes, their risk factors and association with knowledge of diabetes 
in rural Bangladesh: The Bangladesh Population‐based Diabetes and Eye Study. J 
Diabetes 2016;8:260–8. doi:10.1111/1753-0407.12294 
79  Leiter LA, Barr A, Belanger A, et al. Diabetes screening in Canada (DIASCAN) 
study: Prevalence of undiagnosed diabetes and glucose intolerance in family 
physician offices. Diabetes Care Alex 2001;24:1038–43. 
80  Rosella LC, Lebenbaum M, Fitzpatrick T, et al. Prevalence of Prediabetes and 
Undiagnosed Diabetes in Canada (2007–2011) According to Fasting Plasma 
Glucose and HbA1c Screening Criteria. Diabetes Care 2015;38:1299–305. 
doi:10.2337/dc14-2474 
81  Guo F, Moellering DR, Garvey WT. Use of HbA1c for Diagnoses of Diabetes and 
Prediabetes: Comparison with Diagnoses Based on Fasting and 2-Hr Glucose 
83 
 
Values and Effects of Gender, Race, and Age. Metab Syndr Relat Disord 
2014;12:258–68. doi:10.1089/met.2013.0128 
82  Karnchanasorn R, Huang J, Ou H-Y, et al. Comparison of the Current Diagnostic 
Criterion of HbA1c with Fasting and 2-Hour Plasma Glucose Concentration. J 
Diabetes Res 2016;2016. doi:10.1155/2016/6195494 
83  Gregg EW, Cadwell BL, Cheng YJ, et al. Trends in the prevalence and ratio of 
diagnosed to undiagnosed diabetes according to obesity levels in the U.S. Diabetes 
Care 2004;27:2806–12. doi:10.2337/diacare.27.12.2806 
84  Geiss LS, Wang J, Cheng YJ, et al. Prevalence and Incidence Trends for Diagnosed 
Diabetes Among Adults Aged 20 to 79 Years, United States, 1980-2012. JAMA 
2014;312:1218–26. doi:10.1001/jama.2014.11494 
85  Cowie CC, Rust KF, Ford ES, et al. Full Accounting of Diabetes and Pre-Diabetes 
in the U.S. Population in 1988–1994 and 2005–2006. Diabetes Care 2009;32:287–
94. doi:10.2337/dc08-1296 
86  Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for 
diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 
2010;33:562–8. doi:10.2337/dc09-1524 
87  Selvin E, Parrinello CM, Sacks DB, et al. Trends in prevalence and control of 
diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med 
2014;160:517–25. doi:10.7326/M13-2411 
88  Flegal KM, Kruszon-Moran D, Carroll MD, et al. Trends in Obesity Among Adults 
in the United States, 2005 to 2014. JAMA 2016;315:2284–91. 
doi:10.1001/jama.2016.6458 
89  Fryar CD, Carroll MD, Ogden C, et al. Prevalence of Overweight and Obesity 
Among Children and Adolescents: United States, 1963–1965 Through 2011–2012. 
2014. 
90  Selvin E, Wang D, Lee AK, et al. Identifying Trends in Undiagnosed Diabetes in 
U.S. Adults by Using a Confirmatory Definition: A Cross-sectional Study. Ann 
Intern Med 2017;167:769. doi:10.7326/M17-1272 
91  Heidemann C, Du Y, Paprott R, et al. Temporal changes in the prevalence of 
diagnosed diabetes, undiagnosed diabetes and prediabetes: findings from the 
German Health Interview and Examination Surveys in 1997–1999 and 2008–2011. 
Diabet Med 2016;33:1406–14. doi:10.1111/dme.13008 
92  Tjepkema M. Adult obesity in Canada: Measured height and weight. 2005. 
https://www150.statcan.gc.ca/n1/pub/82-620-m/2005001/pdf/4224906-eng.pdf 
(accessed 12 Nov 2019). 
84 
 
93  Torrance GM, Hooper MD, Reeder BA. Trends in overweight and obesity among 
adults in Canada (1970–1992): evidence from national surveys using measured 
height and weight. Int J Obes 2002;26:797–804. doi:10.1038/sj.ijo.0801991 
94  Kim O, Ovbiagele B, Valle N, et al. Race-Ethnic Disparities in Cardiometabolic 
Risk Profiles among Stroke Survivors with Undiagnosed Diabetes and Prediabetes 
in the United States. J Stroke Cerebrovasc Dis 2017;26:2727–33. 
doi:10.1016/j.jstrokecerebrovasdis.2017.06.037 
95  Gregg EW, Zhuo X, Cheng YJ, et al. Trends in lifetime risk and years of life lost 
due to diabetes in the USA, 1985-2011: a modelling study. Lancet Diabetes 
Endocrinol 2014;2:867–74. doi:10.1016/S2213-8587(14)70161-5 
96  The NS, Richardson AS, Gordon-Larsen P. Timing and duration of obesity in 
relation to diabetes: findings from an ethnically diverse, nationally representative 
sample. Diabetes Care 2013;36:865-. 
97  Moody A, Cowley G, Fat LN, et al. Social inequalities in prevalence of diagnosed 
and undiagnosed diabetes and impaired glucose regulation in participants in the 
Health Surveys for England series. BMJ Open 2016;6:e010155. 
doi:10.1136/bmjopen-2015-010155 
98  Arroyo-Johnson C, Mincey KD. Obesity epidemiology trends by race/ethnicity, 
gender, and education: National Health Interview Survey, 1997–2012. 
Gastroenterol Clin North Am 2016;45:571–9. doi:10.1016/j.gtc.2016.07.012 
99  Zhang Q, Wang Y, Huang ES. Changes in racial/ethnic disparities in the prevalence 
of Type 2 diabetes by obesity level among US adults. Ethn Health 2009;14:439–57. 
doi:10.1080/13557850802699155 
100  Smith JP. Nature and Causes of Trends in Male Diabetes Prevalence, Undiagnosed 
Diabetes, and the Socioeconomic Status Health Gradient. Proc Natl Acad Sci U S A 
2007;104:13225–31. 
101  Dwyer-Lindgren L, Mackenbach JP, Lenthe FJ van, et al. Diagnosed and 
Undiagnosed Diabetes Prevalence by County in the U.S., 1999–2012. Diabetes 
Care 2016;39:1556–62. doi:10.2337/dc16-0678 
102  Zhang X, Beckles GL, Bullard KM, et al. Access to health care and undiagnosed 
diabetes along the United States-Mexico border. Rev Panam Salud Publica Pan Am 
J Public Health 2010;28:182–9. doi:10.1590/s1020-49892010000900008 
103  Zhang X, Geiss LS, Cheng YJ, et al. The Missed Patient With Diabetes: How access 




104  Roche MM, Wang PP. Factors associated with a diabetes diagnosis and late diabetes 
diagnosis for males and females. J Clin Transl Endocrinol 2014;1:77–84. 
doi:10.1016/j.jcte.2014.07.002 
105  Lee Y-H, Bang H, Kim HC, et al. A simple screening score for diabetes for the 
Korean population: development, validation, and comparison with other scores. 
Diabetes Care 2012;35:1723–30. doi:10.2337/dc11-2347 
106  Qin X, Li J, Zhang Y, et al. Prevalence and associated factors of diabetes and 
impaired fasting glucose in Chinese hypertensive adults aged 45 to 75 years. PloS 
One 2012;7:e42538. doi:10.1371/journal.pone.0042538 
107  Williams DEM, Wareham NJ, Cox BD, et al. Frequent Salad Vegetable 
Consumption Is Associated with A Reduction in the Risk of Diabetes Mellitus. J 
Clin Epidemiol 1999;52:329–35. doi:10.1016/S0895-4356(99)00006-2 
108  Zhou X, Pang Z, Gao W, et al. Fresh vegetable intake and prevalence of diabetes in 
a Chinese population in Qingdao. Diabetes Res Clin Pract 2011;92:137–42. 
doi:10.1016/j.diabres.2010.12.034 
109  Fink A, Buchmann N, Tegeler C, et al. Physical activity and cohabitation status 
moderate the link between diabetes mellitus and cognitive performance in a 
community-dwelling elderly population in Germany. PLoS ONE 2017;12. 
doi:10.1371/journal.pone.0187119 
110  Canadian Institute for Health Information. Health Indicators 2011: Definitions, Data 
Sources and Rationale. Ottawa Ont: : Canadian Institute for Health Information 
2011. http://publications.gc.ca/collections/collection_2011/icis-cihi/H118-65-2011-
eng.pdf 
111  Saver BG, Wang C-Y, Dobie SA, et al. The central role of comorbidity in predicting 
ambulatory care sensitive hospitalizations*. Eur J Public Health 2014;24:66–72. 
doi:10.1093/eurpub/ckt019 
112  Alonso-Moran E, Orueta JF, Esteban JIF, et al. The prevalence of diabetes-related 
complications and multimorbidity in the population with type 2 diabetes mellitus in 
the Basque Country. BMC Public Health 2014;14. 
http://link.galegroup.com/apps/doc/A539696356/AONE?u=lond95336&sid=AONE
&xid=8bfcc7e7 (accessed 17 Jun 2019). 
113  Thygesen LC, Christiansen T, Garcia-Armesto S, et al. Potentially avoidable 
hospitalizations in five European countries in 2009 and time trends from 2002 to 
2009 based on administrative data. Eur J Public Health 2015;25 Suppl 1:35–43. 
doi:10.1093/eurpub/cku227 
114  Birtwhistle R, Green ME, Frymire E, et al. Hospital admission rates and emergency 
department use in relation to glycated hemoglobin in people with diabetes mellitus: 
86 
 
a linkage study using electronic medical record and administrative data in Ontario. 
CMAJ Open 2017;5:E557–64. doi:10.9778/cmajo.20170017 
115  Gómez-Huelgas R, Lara-Rojas CM, López-Carmona MD, et al. Trends in Diabetes-
Related Potentially Preventable Hospitalizations in Adult Population in Spain, 
1997–2015: A Nation-Wide Population-Based Study. J Clin Med 2019;8:492. 
116  Wang J, Imai K, Engelgau MM, et al. Secular trends in diabetes-related preventable 
hospitalizations in the United States, 1998-2006. Diabetes Care 2009;32:1213-. 
117  Rubens M, Saxena A, Ramamoorthy V, et al. Trends in Diabetes-Related 
Preventable Hospitalizations in the U.S., 2005–2014. Diabetes Care 2018;41:e72–3. 
doi:10.2337/dc17-1942 
118  Kornelius E, Huang C-N, Yang Y-S, et al. Diabetes-related avoidable 
hospitalizations in Taiwan. Prim Care Diabetes 2014;8:330–7. 
doi:10.1016/j.pcd.2014.02.001 
119  Chen P-C, Tsai C-Y, Woung L-C, et al. Socioeconomic disparities in preventable 
hospitalization among adults with diabetes in Taiwan: a multilevel modelling 
approach. Int J Equity Health 2015;14:31. doi:10.1186/s12939-015-0160-4 
120  Booth GL, Hux JE. Relationship Between Avoidable Hospitalizations for Diabetes 
Mellitus and Income Level. Arch Intern Med 2003;163:101–6. 
doi:10.1001/archinte.163.1.101 
121  Sajjad MA, Holloway-Kew KL, Mohebbi M, et al. Association between area-level 
socioeconomic status, accessibility and diabetes-related hospitalisations: a cross-
sectional analysis of data from Western Victoria, Australia. BMJ Open 
2019;9:e026880. doi:10.1136/bmjopen-2018-026880 
122  Campbell DJ, Lacny SL, Weaver RG, et al. Age modification of diabetes-related 
hospitalization among First Nations adults in Alberta, Canada. Diabetol Metab 
Syndr 2014;6. doi:10.1186/1758-5996-6-108 
123  Ng E, McGrail KM, Johnson JA. Hospitalization risk in a type 2 diabetes cohort. 
Health Rep 2010;21:29–35. 
124  Chen Y, Jiang Y, Mao Y. Hospital admissions associated with body mass index in 
Canadian adults. Int J Obes 2007;31:962–7. doi:10.1038/sj.ijo.0803530 
125  Schafer MH, Ferraro KF. Long-term Obesity and Avoidable Hospitalization Among 
Younger, Middle-aged, and Older Adults. Arch Intern Med 2007;167:2220–5. 
doi:10.1001/archinte.167.20.2220 
126  Carriere GM, Kumar MB, Sanmartin C. Hospitalization for ambulatory care 
sensitive conditions among urban Metis adults. Health Rep 2017;28:3-. 
87 
 
127  Jin A, Martin JD, Sarin C. Diabetes mellitus in the First Nations population of 
British Columbia, Canada. Part 2. Hospital morbidity. Int J Circumpolar Health 
2002;61:254–9. doi:10.3402/ijch.v61i3.17459 
128  Ronksley PE, Ravani P, Sanmartin C, et al. Patterns of engagement with the health 
care system and risk of subsequent hospitalization amongst patients with diabetes. 
BMC Health Serv Res 2013;13:399. doi:10.1186/1472-6963-13-399 
129  Burke V, Zhao Y, Lee AH, et al. Predictors of type 2 diabetes and diabetes-related 
hospitalisation in an Australian Aboriginal cohort. Diabetes Res Clin Pract 
2007;78:360–8. doi:10.1016/j.diabres.2007.04.007 
130  Weinstein E, Galindo R, Fried M, et al. Impact of a Focused Nutrition Educational 
Intervention Coupled With Improved Access to Fresh Produce on Purchasing 
Behavior and Consumption of Fruits and Vegetables in Overweight Patients With 
Diabetes Mellitus. Diabetes Educ 2014;40:100–6. doi:10.1177/0145721713508823 
131  Mwita JC, Magafu MGMD, Omech B, et al. Undiagnosed and diagnosed diabetes 
mellitus among hospitalised acute heart failure patients in Botswana. SAGE Open 
Med 2017;5:2050312117731473. doi:10.1177/2050312117731473 
132  Kristensen SL, Jhund PS, Lee MMY, et al. Prevalence of Prediabetes and 
Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical 
Outcomes. Cardiovasc Drugs Ther 2017;31:545–9. doi:10.1007/s10557-017-6754-x 
133  Gray CS, Scott JF, French JM, et al. Prevalence and prediction of unrecognised 
diabetes mellitus and impaired glucose tolerance following acute stroke. Age Ageing 
2004;33:71–7. doi:10.1093/ageing/afh026 
134  Ertorer ME, Haydardedeoglu FE, Erol T, et al. Newly diagnosed hyperglycemia and 
stress hyperglycemia in a coronary intensive care unit. Diabetes Res Clin Pract 
2010;90:8–14. doi:10.1016/j.diabres.2010.05.023 
135  Plantinga LC, Crews DC, Coresh J, et al. Prevalence of Chronic Kidney Disease in 
US Adults with Undiagnosed Diabetes or Prediabetes. Clin J Am Soc Nephrol 
2010;5:673–82. doi:10.2215/CJN.07891109 
136  Statistics Canada. Canadian Community Health Survey Data (2000 to 2011) Linked 
to the Discharge Abstract Database (1999/2000-2012/2013). Stat. Can. 2018. 
https://www.statcan.gc.ca/eng/rdc/cencchs-dad (accessed 3 Nov 2019). 
137  Statistics Canada. Canadian Community Health Survey (CCHS) 2007 Microdata 
files User guide. 2008. http://www23.statcan.gc.ca/imdb-
bmdi/pub/document/3226_D7_T9_V4-eng.pdf (accessed 29 Apr 2019). 
138  Béland Y. Canadian Community Health Survey — Methodological overview. 
Health Rep 2002;13:6. 
88 
 





cs%20Canada%2C%202017). (accessed 2 Dec 2019). 
140  Government of Canada SC. Canadian Community Health Survey (CCHS) – Annual 
component. 2010. https://www.statcan.gc.ca/eng/statistical-
programs/document/3226_D56_T9_V1 (accessed 2 Dec 2019). 
141  Brisebois F, Thivierge S, Statistics Canada. The Weighting Strategy of the Canadian 
Community Health Survey. 2001. 
https://data.library.ubc.ca/rdc/pdf/CCHSWeightingStrategy.pdf (accessed 30 Jul 
2019). 
142  Government of Canada SC. Canadian Community Health Survey (CCHS). 
2007.http://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&Id=3359 
(accessed 30 Jul 2019). 
143  Government of Canada SC. Canadian Community Health Survey - Annual 
Component (CCHS). 
2010.http://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&Id=67251 
(accessed 30 Jul 2019). 
144  Canadian Institute for Health Information. Data Quality Documentation, Discharge 
Abstract Database—Multi-Year Information. 2012. 
https://www.cihi.ca/sites/default/files/dad_multi-year_en_0.pdf (accessed 30 Jul 
2019). 
145  World Health Organization. International Classification of Diseases, 11th Revision 
(ICD-11). WHO. http://www.who.int/classifications/icd/en/ (accessed 25 Jul 2019). 
146  Centers for Disease Control and Prevention, National Center for Health Statistics. 
International Classification of Diseases, Ninth Revision, Clinical Modification. 
Cent. Dis. Control Prev. 2019.https://www.cdc.gov/nchs/icd/icd9cm.htm (accessed 
5 Nov 2019). 
147  Canadian Institute for Health Information. Version 2018 ICD-10-CA/CCI, Canadian 
Coding Standards and related products. 2018. 
https://www.cihi.ca/en/bulletin/version-2018-icd-10-cacci-canadian-coding-
standards-and-related-products (accessed 30 Jul 2019). 
148  Dugan J, Shubrook J. International Classification of Diseases, 10th Revision, 
Coding for Diabetes. Clin Diabetes 2017;35:232–8. doi:10.2337/cd16-0052 
149  Centers for Medicare and Medicaid Services, National Center for Health Statistics, 
Health and Human Services. ICD-9-CM Official Guidelines for Coding and 
89 
 
Reporting. 2011. https://www.cdc.gov/nchs/data/icd/icd9cm_guidelines_2011.pdf 
(accessed 5 Nov 2019). 
150  Sayers A, Ben-Shlomo Y, Blom AW, et al. Probabilistic record linkage. Int J 
Epidemiol 2016;45:954–64. doi:10.1093/ije/dyv322 
151  Statistics Canada. Summary Report of the Canadian Community Health Survey 
(CCHS .1) – Discharge Abstract Database (DAD) Record Linkage Study. Health 
Statistics Division 2016. Available upon request (accessed 1 Nov 2019). 
152  Brower KJ, Krentzman A, Robinson EAR. Persistent insomnia, abstinence, and 
moderate drinking in alcohol-dependent individuals. Am J Addict 2011;20:435–40. 
doi:10.1111/j.1521-0391.2011.00152.x 
153  Dashti HS, Scheer FA, Jacques PF, et al. Short sleep duration and dietary  intake: 
epidemiologic evidence, mechanisms, and health implications. Adv Nutr 
2015;6:648–59. doi:10.3945/an.115.008623 
154  Knowlden A, Petrov M, Nowakowski S, et al. 0278 Gender differences in the 
relationship between short sleep and obesity depend on age. Sleep 2018;41:A107–
A107. doi:10.1093/sleep/zsy061.277 
155  Lydon-Staley DM, Ram N, Brose A, et al. Reduced impact of alcohol use on next-
day tiredness in older relative to younger adults: a role for sleep duration. Psychol 
Aging 2017;32:642–53. doi:10.1037/pag0000198 
156  Nelson LM, Longstreth WT, Koepsell TD, et al. Completeness and accuracy of 
interview data from proxy respondents: demographic, medical, and life-style factors. 
Epidemiol Camb Mass 1994;5:204–17. 
157  Rubin DB. Inference and Missing Data. Biometrika 1976;63:581–92. 
doi:10.2307/2335739 
158  Brisebois F, Mathieu P, Bédard M. Hands-on Workshop on the use of Health 
Surveys data (NPHS & CCHS). 
2017.http://www.ciqss.umontreal.ca/Docs/Formations/Ateliers/2003-11-
27_UseofData.pdf (accessed 2 Nov 2019). 
159  Kang H. The prevention and handling of the missing data. Korean J Anesthesiol 
2013;64:402–6. doi:10.4097/kjae.2013.64.5.402 
160  Bodner TE. What Improves with Increased Missing Data Imputations? Struct Equ 
Model Multidiscip J 2008;15:651–75. doi:10.1080/10705510802339072 
161  Pandey KR, Yang F, Cagney KA, et al. The impact of marital status on health care 




162  Fiegehen GC, Lansley PS. The Measurement of Poverty: A Note on Household Size 
and Income Units. J R Stat Soc Ser Gen 1976;139:508–18. doi:10.2307/2344353 
163  Statistics Canada. Complete A to Z index. 2010.https://www12.statcan.gc.ca/census-
recensement/2006/ref/dict/azindex-eng.cfm#U (accessed 2 Dec 2019). 
164  Papier K, Appleby PN, Fensom GK, et al. Vegetarian diets and risk of 
hospitalisation or death with diabetes in British adults: results from the EPIC-
Oxford study. Nutr Diabetes 2019;9:1–8. doi:10.1038/s41387-019-0074-0 
165  St-Pierre M, Béland Y. Mode effects in the Canadian Community Health Survey: A 
comparison of CAPI and CATI. In: Proceedings of the Annual Meeting of the 
American Statistical Association, Survey Research Methods Section, August 2004. 
2004.  
166  Johnson JL, Greaves L, Repta R. Better science with sex and gender: facilitating the 
use of a sex and gender-based analysis in health research. Int J Equity Health 
2009;8:14. doi:10.1186/1475-9276-8-14 
167  Exploring the biological contributions to human health: does sex matter?". 
Washington, DC: 2001. doi:10.17226/10028 
168  SAS institute Inc. PROC SURVEYFREQ: Overview :: SAS/STAT(R) 9.22 User’s 
Guide. 
2018.https://support.sas.com/documentation/cdl/en/statug/63347/HTML/default/vie
wer.htm#statug_surveyfreq_sect001.htm (accessed 7 Nov 2019). 
169  SAS institute Inc. PROC SURVEYMEANS: Overview :: SAS/STAT(R) 9.2 User’s 
Guide, Second Edition. 
2018.https://support.sas.com/documentation/cdl/en/statug/63033/HTML/default/vie
wer.htm#statug_surveymeans_sect001.htm (accessed 7 Nov 2019). 
170  Statistics Canada. Canadian Community Health Survey (CCHS) – Household 
weights documentation. 2010.http://www23.statcan.gc.ca/imdb-
bmdi/pub/document/3226_D57_T9_V1-eng.htm (accessed 11 Nov 2019). 
171  Gagné C, Roberts G, Keown L-A. Weighted estimation and bootstrap variance 
estimation for analyzing survey data: How to implement in selected software. 
2014.https://www150.statcan.gc.ca/n1/pub/12-002-x/2014001/article/11901-
eng.htm#a1 (accessed 11 Nov 2019). 
172  SAS institute Inc. SAS 9.4 Software. https://www.sas.com/en_ca/software/sas9.html 
(accessed 2 Dec 2019). 
173  Logue J, Walker JJ, Colhoun HM, et al. Do men develop type 2 diabetes at lower 




174  Power ML, Schulkin J. Sex differences in fat storage, fat metabolism, and the health 
risks from obesity: possible evolutionary origins. Br J Nutr 2008;99:931–40. 
doi:10.1017/S0007114507853347 
175  Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends 
in body-mass index since 1980: systematic analysis of health examination surveys 
and epidemiological studies with 960 country-years and 9·1 million participants. 
The Lancet 2011;377:557–67. doi:10.1016/S0140-6736(10)62037-5 
176  Statistics Canada. Adult body mass index (BMI). 
2016.https://www150.statcan.gc.ca/n1/pub/82-229-x/2009001/status/abm-eng.htm 
(accessed 19 Nov 2019). 
177  Twells LK, Gregory DM, Reddigan J, et al. Current and predicted prevalence of 
obesity in Canada: a trend analysis. CMAJ Open 2014;2:E18–26. 
doi:10.9778/cmajo.20130016 
178  Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of 
overweight and obesity in children and adults during 1980-2013: a systematic 
analysis for the Global Burden of Disease Study 2013. Lancet Lond Engl 
2014;384:766–81. doi:10.1016/S0140-6736(14)60460-8 
179  Laberge M, Leclerc M. Immigration factors and potentially avoidable 
hospitalizations in Canada. SSM - Popul Health 2019;7:100336. 
doi:10.1016/j.ssmph.2018.100336 
180  Statistics Canada. Adults who are overweight or obese 2008. 
2015.https://www150.statcan.gc.ca/n1/pub/82-625-x/2010001/article/11096-
eng.htm (accessed 19 Nov 2019). 
181  Dawson KA, Schneider MA, Fletcher PC, et al. Examining gender differences in the 
health behaviors of Canadian university students. J R Soc Promot Health 
2007;127:38–44. doi:10.1177/1466424007073205 
182  Nanakorn S, Osaka R, Chusilp K, et al. Gender differences in health-related 
practices among university students in northeast Thailand. Asia Pac J Public Health 
1999;11:10–5. doi:10.1177/101053959901100103 
183  Zhao Y, Wright J, Guthridge S, et al. The relationship between number of primary 
health care visits and hospitalisations: evidence from linked clinic and hospital data 
for remote Indigenous Australians. BMC Health Serv Res 2013;13:466. 
doi:10.1186/1472-6963-13-466 
184  Moss SE, Klein R, Klein BEK. Risk Factors for Hospitalization in People With 
Diabetes. Arch Intern Med 1999;159:2053–7. doi:10.1001/archinte.159.17.2053 
92 
 
185  Government of Canada SC. Heavy Drinking, 2016. 
2017.https://www150.statcan.gc.ca/n1/pub/82-625-x/2017001/article/54861-
eng.htm (accessed 20 Nov 2019). 
186  Schrieks IC, Heil ALJ, Hendriks HFJ, et al. The effect of alcohol consumption on 
insulin sensitivity and glycemic status: a systematic review and meta-analysis of 
intervention studies. Diabetes Care 2015;38:723–32. doi:10.2337/dc14-1556 
187  InterAct Consortium, Spijkerman AMW, van der A DL, et al. Smoking and long-
term risk of type 2 diabetes: the EPIC-InterAct study in European populations. 
Diabetes Care 2014;37:3164–71. doi:10.2337/dc14-1020 
188  Shah BR, Manuel DG. Self-reported diabetes is associated with self-management 
behaviour: a cohort study. BMC Health Serv Res 2008;8:142. doi:10.1186/1472-
6963-8-142 
189  Social Desirability. In: Encyclopedia of Survey Research Methods. 2455 Teller 
Road, Thousand Oaks California 91320 United States of America: : Sage 
Publications, Inc. 2008. doi:10.4135/9781412963947.n537 
190  Sentell TL, Seto TB, Young MM, et al. Pathways to potentially preventable 
hospitalizations for diabetes and heart failure: a qualitative analysis of patient 
perspectives. BMC Health Serv Res 2016;16. doi:10.1186/s12913-016-1511-6 
191  Ahern MM, Hendryx M. Avoidable hospitalizations for diabetes: comorbidity risks. 
Dis Manag DM 2007;10:347–55. doi:10.1089/dis.2007.106709 
192  Carral F, Olveira G, Aguilar M, et al. Hospital discharge records under-report the 
prevalence of diabetes in inpatients. Diabetes Res Clin Pract 2003;59:145–51. 
doi:10.1016/S0168-8227(02)00200-0 
193  Levetan CS, Passaro M, Jablonski K, et al. Unrecognized diabetes among 
hospitalized patients. Diabetes Care Alex 1998;21:246–9. 
doi:http://dx.doi.org.proxy1.lib.uwo.ca/10.2337/diacare.21.2.246 
194  Wexler DJ, Nathan DM, Grant RW, et al. Prevalence of elevated hemoglobin A1c 
among patients admitted to the hospital without a diagnosis of diabetes. J Clin 
Endocrinol Metab 2008;93:4238–44. doi:10.1210/jc.2008-1090 
195  Heckley G, Jarl J, Gerdtham U-G. Frequency and intensity of alcohol consumption: 
new evidence from Sweden. Eur J Health Econ 2017;18:495–517. 
doi:10.1007/s10198-016-0805-2 
196  Hajian-Tilaki K, Heidari B. Is Waist Circumference A Better Predictor of Diabetes 
Than Body Mass Index Or Waist-To-Height Ratio In Iranian Adults? Int J Prev 
Med 2015;6. doi:10.4103/2008-7802.151434 
93 
 
197  Aye M, Sazali M. Waist circumference and BMI cut-off points to predict risk 
factors for metabolic syndrome among outpatients in a district hospital. Singapore 


















25020 DIABETES MELLITUS WITH 
HYPEROSMOLARITY TYPE II OR 
UNSPECIFIED TYPE NOT STATED 
AS UNCONTROLLED 
  
25022 DIABETES MELLITUS WITH 
HYPEROSMOLARITY TYPE II OR 
UNSPECIFIED TYPE 
UNCONTROLLED 




25020 DIABETES MELLITUS WITH 
HYPEROSMOLARITY TYPE II OR 
UNSPECIFIED TYPE NOT STATED 
AS UNCONTROLLED   
25032 DIABETES MELLITUS WITH 
OTHER COMA TYPE II OR 
UNSPECIFIED TYPE 
UNCONTROLLED 
E1121 TYPE 2 DIABETES 
MELLITUS WITH DIABETIC 
NEPHROPATHY 
25042 DIABETES MELLITUS WITH 
RENAL MANIFESTATIONS TYPE II 
OR UNSPECIFIED TYPE 
UNCONTROLLED 
E1129 TYPE 2 DIABETES 
MELLITUS WITH OTHER 
DIABETIC KIDNEY 
COMPLICATION 
25040 DIABETES MELLITUS WITH 
RENAL MANIFESTATIONS TYPE II 
OR UNSPECIFIED TYPE NOT 
STATED AS UNCONTROLLED 





25050 DIABETES MELLITUS WITH 
OPHTHALMIC MANIFESTATIONS 
TYPE II OR UNSPECIFIED TYPE 
NOT STATED AS UNCONTROLLED 
  
25052 DIABETES MELLITUS WITH 
OPHTHALMIC MANIFESTATIONS 
TYPE II OR UNSPECIFIED TYPE 
UNCONTROLLED   
36207 DIABETIC MACULAR EDEMA 
E11319 TYPE 2 DIABETES 
MELLITUS WITH 







TYPE II OR UNSPECIFIED TYPE 
NOT STATED AS UNCONTROLLED 
  
25052 DIABETES MELLITUS WITH 
OPHTHALMIC MANIFESTATIONS 
TYPE II OR UNSPECIFIED TYPE 
UNCONTROLLED   
36201 BACKGROUND DIABETIC 
RETINOPATHY 
E11329 TYPE 2 DIABETES 





36203 NONPROLIFERATIVE DIABETIC 
RETINOPATHY NOS 
  
36204 MILD NONPROLIFERATIVE 
DIABETIC RETINOPATHY 







36205 MODERATE NONPROLIFERATIVE 
DIABETIC RETINOPATHY 
E11349 TYPE 2 DIABETES 





36206 SEVERE NONPROLIFERATIVE 
DIABETIC RETINOPATHY 





36202 PROLIFERATIVE DIABETIC 
RETINOPATHY 
E1136 TYPE 2 DIABETES 
MELLITUS WITH DIABETIC 
CATARACT 
25050 DIABETES MELLITUS WITH 
OPHTHALMIC MANIFESTATIONS 
TYPE II OR UNSPECIFIED TYPE 
NOT STATED AS UNCONTROLLED   
25052 DIABETES MELLITUS WITH 
OPHTHALMIC MANIFESTATIONS 
TYPE II OR UNSPECIFIED TYPE 
UNCONTROLLED   
36641 DIABETIC CATARACT 
96 
 
E1139 TYPE 2 DIABETES 
MELLITUS WITH OTHER 
DIABETIC OPHTHALMIC 
COMPLICATION 
25050 DIABETES MELLITUS WITH 
OPHTHALMIC MANIFESTATIONS 
TYPE II OR UNSPECIFIED TYPE 
NOT STATED AS UNCONTROLLED   
25052 DIABETES MELLITUS WITH 
OPHTHALMIC MANIFESTATIONS 
TYPE II OR UNSPECIFIED TYPE 
UNCONTROLLED 
E1140 TYPE 2 DIABETES 
MELLITUS WITH DIABETIC 
NEUROPATHY, 
UNSPECIFIED 
25060 DIABETES MELLITUS WITH 
NEUROLOGICAL 
MANIFESTATIONS TYPE II OR 
UNSPECIFIED TYPE NOT STATED 
AS UNCONTROLLED   
25062 DIABETES MELLITUS WITH 
NEUROLOGICAL 
MANIFESTATIONS TYPE II OR 
UNSPECIFIED TYPE 
UNCONTROLLED 
E1142 TYPE 2 DIABETES 
MELLITUS WITH DIABETIC 
POLYNEUROPATHY 
3572 POLYNEUROPATHY IN DIABETES 
E1151 TYPE 2 DIABETES 




25070 DIABETES MELLITUS WITH 
PERIPHERAL CIRCULATORY 
DISORDERS TYPE II OR 
UNSPECIFIED TYPE NOT STATED 
AS UNCONTROLLED   
25072 DIABETES MELLITUS WITH 
PERIPHERAL CIRCULATORY 
DISORDERS TYPE II OR 
UNSPECIFIED TYPE 
UNCONTROLLED 
E11618 TYPE 2 DIABETES 
MELLITUS WITH OTHER 
DIABETIC ARTHROPATHY 
25080 DIABETES MELLITUS WITH 
OTHER SPECIFIED 
MANIFESTATIONS TYPE II OR 
UNSPECIFIED TYPE NOT STATED 
AS UNCONTROLLED 
E11620 TYPE 2 DIABETES 
MELLITUS WITH DIABETIC 
DERMATITIS 
25080 DIABETES MELLITUS WITH 
OTHER SPECIFIED 
MANIFESTATIONS TYPE II OR 
UNSPECIFIED TYPE NOT STATED 
AS UNCONTROLLED 
E11621 TYPE 2 DIABETES 
MELLITUS WITH FOOT 
ULCER 
25080 DIABETES MELLITUS WITH 
OTHER SPECIFIED 
MANIFESTATIONS TYPE II OR 
97 
 
UNSPECIFIED TYPE NOT STATED 
AS UNCONTROLLED 
E11622 TYPE 2 DIABETES 
MELLITUS WITH OTHER 
SKIN ULCER 
25080 DIABETES MELLITUS WITH 
OTHER SPECIFIED 
MANIFESTATIONS TYPE II OR 
UNSPECIFIED TYPE NOT STATED 
AS UNCONTROLLED 
E11628 TYPE 2 DIABETES 
MELLITUS WITH OTHER 
SKIN COMPLICATIONS 
25080 DIABETES MELLITUS WITH 
OTHER SPECIFIED 
MANIFESTATIONS TYPE II OR 
UNSPECIFIED TYPE NOT STATED 
AS UNCONTROLLED 
E11630 TYPE 2 DIABETES 
MELLITUS WITH 
PERIODONTAL DISEASE 
25080 DIABETES MELLITUS WITH 
OTHER SPECIFIED 
MANIFESTATIONS TYPE II OR 
UNSPECIFIED TYPE NOT STATED 
AS UNCONTROLLED 
E11638 TYPE 2 DIABETES 
MELLITUS WITH OTHER 
ORAL COMPLICATIONS 
25080 DIABETES MELLITUS WITH 
OTHER SPECIFIED 
MANIFESTATIONS TYPE II OR 
UNSPECIFIED TYPE NOT STATED 
AS UNCONTROLLED 




25030 DIABETES MELLITUS WITH 
OTHER COMA TYPE II OR 
UNSPECIFIED TYPE NOT STATED 
AS UNCONTROLLED 




25080 DIABETES MELLITUS WITH 
OTHER SPECIFIED 
MANIFESTATIONS TYPE II OR 
UNSPECIFIED TYPE NOT STATED 
AS UNCONTROLLED 
E1165 TYPE 2 DIABETES 
MELLITUS WITH 
HYPERGLYCEMIA 
25002 DIABETES MELLITUS WITHOUT 
COMPLICATION TYPE II OR 
UNSPECIFIED TYPE 
UNCONTROLLED   
25012 DIABETES MELLITUS WITH 
KETOACIDOSIS TYPE II OR 
UNSPECIFIED TYPE 
UNCONTROLLED   
25022 DIABETES MELLITUS WITH 
HYPEROSMOLARITY TYPE II OR 
UNSPECIFIED TYPE 
UNCONTROLLED   
25032 DIABETES MELLITUS WITH 




UNCONTROLLED   
25042 DIABETES MELLITUS WITH 
RENAL MANIFESTATIONS TYPE II 
OR UNSPECIFIED TYPE 
UNCONTROLLED   
25052 DIABETES MELLITUS WITH 
OPHTHALMIC MANIFESTATIONS 
TYPE II OR UNSPECIFIED TYPE 
UNCONTROLLED   
25062 DIABETES MELLITUS WITH 
NEUROLOGICAL 
MANIFESTATIONS TYPE II OR 
UNSPECIFIED TYPE 
UNCONTROLLED   
25072 DIABETES MELLITUS WITH 
PERIPHERAL CIRCULATORY 
DISORDERS TYPE II OR 
UNSPECIFIED TYPE 
UNCONTROLLED   
25080 DIABETES MELLITUS WITH 
OTHER SPECIFIED 
MANIFESTATIONS TYPE II OR 
UNSPECIFIED TYPE NOT STATED 
AS UNCONTROLLED   
25082 DIABETES MELLITUS WITH 
OTHER SPECIFIED 
MANIFESTATIONS TYPE II OR 
UNSPECIFIED TYPE 
UNCONTROLLED   
25092 DIABETES MELLITUS WITH 
UNSPECIFIED COMPLICATION 
TYPE II OR UNSPECIFIED TYPE 
UNCONTROLLED 
E1169 TYPE 2 DIABETES 
MELLITUS WITH OTHER 
SPECIFIED 
COMPLICATION 
25010 DIABETES MELLITUS WITH 
KETOACIDOSIS TYPE II OR 
UNSPECIFIED TYPE NOT STATED 
AS UNCONTROLLED   
25012 DIABETES MELLITUS WITH 
KETOACIDOSIS TYPE II OR 
UNSPECIFIED TYPE 
UNCONTROLLED   
25080 DIABETES MELLITUS WITH 
OTHER SPECIFIED 
MANIFESTATIONS TYPE II OR 
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UNSPECIFIED TYPE NOT STATED 
AS UNCONTROLLED   
25082 DIABETES MELLITUS WITH 
OTHER SPECIFIED 
MANIFESTATIONS TYPE II OR 
UNSPECIFIED TYPE 
UNCONTROLLED 




25090 DIABETES MELLITUS WITH 
UNSPECIFIED COMPLICATION 
TYPE II OR UNSPECIFIED TYPE 
NOT STATED AS UNCONTROLLED   
25092 DIABETES MELLITUS WITH 
UNSPECIFIED COMPLICATION 
TYPE II OR UNSPECIFIED TYPE 
UNCONTROLLED 
E119 TYPE 2 DIABETES 
MELLITUS WITHOUT 
COMPLICATIONS 
25000 DIABETES MELLITUS WITHOUT 
COMPLICATION TYPE II OR 
























Appendix B: Association between sociodemographic, health-related and 
behavioural predictors and type 2 diabetes related hospitalization among adults 














1.07 1.03 1.12 0.0007* 1.04 1.00 1.08 0.0348* 
Type of 
Interview 
1.15 0.85 1.56 0.3543 0.93 0.74 1.16 0.5145 
Age 3.40 2.30 5.02 <.0001* 1.96 1.29 2.97 0.0018* 
Age^2 0.93 0.89 0.97 0.0011* 0.98 0.94 1.02 0.316 
Visible 
Minority 
1.24 0.65 2.36 0.5157 1.63 1.11 2.41 0.0133* 
Marital 
status 
0.89 0.66 1.21 0.4713 1.33 0.95 1.86 0.1023 
Education 0.94 0.73 1.20 0.5988 0.92 0.72 1.19 0.5345 
Income 0.96 0.91 1.01 0.1047 0.93 0.87 1.00 0.0481* 
Household 
size 
0.90 0.76 1.07 0.2199 0.76 0.64 0.90 0.0021* 
Rurality 1.08 0.82 1.42 0.6031 1.13 0.87 1.46 0.3805 








1.68 1.12 2.52 0.0124* 1.53 0.89 2.64 0.1245 
Visit doctor 
in past 12 
months 
1.52 1.02 2.27 0.0385* 0.81 0.55 1.20 0.2917 
Alcohol 
drinking 
1.00 0.77 1.31 0.9799 0.75 0.59 0.95 0.0164* 
Smoking  1.06 0.81 1.38 0.6662 1.48 1.08 2.03 0.0143* 
Physical 
activity 
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